Regulation	O
of	O
IL-6	B-protein
synthesis	O
in	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cells	I-cell_type
by	O
C3a	B-protein
and	O
C3a	B-protein
(	I-protein
desArg	I-protein
)	I-protein
.	O

The	O
anaphylatoxin	B-protein
C3a	B-protein
has	O
been	O
reported	O
to	O
have	O
immunomodulatory	O
effects	O
on	O
a	O
number	O
of	O
different	O
cell	O
types	O
.	O

In	O
this	O
study	O
we	O
investigated	O
the	O
effects	O
of	O
C3a	B-protein
and	O
C3a	B-protein
(	I-protein
desArg	I-protein
)	I-protein
on	O
gene	O
expression	O
and	O
protein	O
secretion	O
of	O
IL-6	B-protein
in	O
human	O
PBMCs	B-cell_type
,	O
either	O
alone	O
or	O
in	O
combination	O
with	O
LPS	O
or	O
IL-1beta	B-protein
.	O

C3a	B-protein
or	O
C3a	B-protein
(	I-protein
desArg	I-protein
)	I-protein
alone	O
exhibited	O
no	O
effect	O
on	O
the	O
expression	O
or	O
secretion	O
of	O
IL-6	B-protein
.	O

However	O
,	O
when	O
PBMC	B-cell_type
were	O
stimulated	O
with	O
LPS	O
or	O
IL-1beta	B-protein
,	O
both	O
C3a	B-protein
and	O
C3a	B-protein
(	I-protein
desArg	I-protein
)	I-protein
were	O
found	O
to	O
enhance	O
IL-6	B-protein
release	O
by	O
PBMC	B-cell_type
in	O
a	O
dose-dependent	O
manner	O
.	O

Since	O
C3a	B-protein
has	O
been	O
shown	O
to	O
induce	O
PGE2	O
production	O
by	O
monocytes	B-cell_type
,	O
and	O
PGE2	O
has	O
been	O
shown	O
to	O
influence	O
cytokine	O
production	O
,	O
we	O
investigated	O
the	O
potential	O
role	O
of	O
PGE2	O
in	O
C3a	B-protein
-mediated	O
enhancement	O
of	O
LPS-	O
and	O
IL-1beta-induced	O
IL-6	O
production	O
.	O

Indomethacin	O
blocked	O
PGE2	O
release	O
,	O
but	O
had	O
no	O
influence	O
on	O
the	O
observed	O
effects	O
of	O
C3a	B-protein
,	O
suggesting	O
that	O
the	O
effects	O
of	O
C3a	B-protein
on	O
IL-6	B-protein
production	O
are	O
independent	O
of	O
PGE2	O
formation	O
by	O
monocytes	B-cell_type
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
C3a	B-protein
as	O
well	O
as	O
C3a	B-protein
(	I-protein
desArg	I-protein
)	I-protein
enhanced	O
LPS	O
-induced	B-RNA
mRNA	I-RNA
levels	O
for	O
IL-6	B-protein
.	O

Pretreatment	O
of	O
PBMCs	B-cell_type
with	O
pertussis	B-protein
toxin	I-protein
blocked	O
the	O
functions	O
of	O
C3a	B-protein
and	O
C3a	B-protein
(	I-protein
desArg	I-protein
)	I-protein
,	O
indicating	O
that	O
the	O
actions	O
of	O
these	O
two	O
molecules	O
are	O
mediated	O
by	O
a	O
G	B-protein
protein	I-protein
-coupled	O
pathway	O
.	O

Furthermore	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
C3a	B-protein
and	O
C3a	B-protein
(	I-protein
desArg	I-protein
)	I-protein
on	O
induction	O
of	O
NF-kappaB	B-protein
and	O
activating	B-protein
protein-1	I-protein
binding	O
.	O

Both	O
molecules	O
enhanced	O
LPS-induced	O
NF-kappaB	B-protein
and	O
activating	B-protein
protein-1	I-protein
binding	O
activity	O
.	O

These	O
results	O
demonstrate	O
the	O
capacity	O
of	O
intact	O
C3a	B-protein
and	O
its	O
circulating	O
des-Arg	B-protein
form	I-protein
to	O
exert	O
immunmodulatory	O
effects	O
in	O
vitro	O
.	O

NNTTETENT	NULL
«	NULL
P50	NULL
a-4-188|	NULL
c-CTh	NULL
*in	NULL
VIVO	NULL
(	NULL
RESEARCH	NULL
*	NULL
Discover	NULL
More	NULL
has	NULL
Ail	NULL
meJournal	NULL
of	NULL
Regulation	NULL
of	NULL
IL-6	NULL
Synthesis	NULL
in	NULL
Human	NULL
4D	NULL
Immunolo	NULL
gy	NULL
Peripheral	NULL
Blood	NULL
Mononuclear	NULL
Cells	NULL
by	NULL
C3a	NULL
and	NULL
C32Gpq	NULL
Arg	NULL
Wolfgang	NULL
H.	NULL
Fischer	NULL
,	NULL
Mark	NULL
A.	NULL
Jagels	NULL
and	NULL
Tony	NULL
E.	NULL
Hugli	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:453-459	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/1/453	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
53	NULL
articles	NULL
,	NULL
23	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/1/453.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Regulation	NULL
of	NULL
IL-6	NULL
Synthesis	NULL
in	NULL
Human	NULL
Peripheral	NULL
Blood	NULL
Mononuclear	NULL
Cells	NULL
by	NULL
C3a	NULL
and	NULL
C3aq	NULL
,	NULL
,	NULL
Argl	NULL
Wolfgang	NULL
H.	NULL
Fischer	NULL
,	NULL
``	NULL
``	NULL
Mark	NULL
A.	NULL
Jagels	NULL
,	NULL
``	NULL
and	NULL
Tony	NULL
E.	NULL
Hugli*	NULL
The	NULL
anaphylatoxin	NULL
C3a	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
have	NULL
immunomodulatory	NULL
effects	NULL
on	NULL
a	NULL
number	NULL
of	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
on	NULL
gene	NULL
expression	NULL
and	NULL
protein	NULL
secretion	NULL
of	NULL
IL-6	NULL
in	NULL
human	NULL
PBMCs	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
LPS	NULL
or	NULL
IL-1	NULL
.	NULL

C3a	NULL
or	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
.	NULL

,	NULL
alone	NULL
exhibited	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
or	NULL
secretion	NULL
of	NULL
IL-6	NULL
.	NULL

However	NULL
,	NULL
when	NULL
PBMC	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
or	NULL
IL-1	NULL
$	NULL
,	NULL
both	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
were	NULL
found	NULL
to	NULL
enhance	NULL
IL-6	NULL
release	NULL
by	NULL
PBMC	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Since	NULL
C3a	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
PGE	NULL
,	NULL
production	NULL
by	NULL
monocytes	NULL
,	NULL
and	NULL
PGE	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
influence	NULL
cytokine	NULL
production	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
PGE	NULL
,	NULL
in	NULL
CJa-mediated	NULL
enhancement	NULL
of	NULL
LPS-	NULL
and	NULL
IL-1	NULL
{	NULL
3-induced	NULL
IL-6	NULL
production	NULL
.	NULL

Indomethacin	NULL
blocked	NULL
PGE	NULL
,	NULL
release	NULL
,	NULL
but	NULL
had	NULL
no	NULL
influence	NULL
on	NULL
the	NULL
observed	NULL
effects	NULL
of	NULL
C3a	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
on	NULL
IL-6	NULL
production	NULL
are	NULL
independent	NULL
of	NULL
PGE	NULL
,	NULL
formation	NULL
by	NULL
monocytes	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
C3a	NULL
as	NULL
well	NULL
as	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
enhanced	NULL
LPS-induced	NULL
mRNA	NULL
levels	NULL
for	NULL
IL-6	NULL
.	NULL

Pretreatment	NULL
of	NULL
PBMCs	NULL
with	NULL
pertussis	NULL
toxin	NULL
blocked	NULL
the	NULL
functions	NULL
of	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
\	NULL
,	NULL
.	NULL

,	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
actions	NULL
of	NULL
these	NULL
two	NULL
molecules	NULL
are	NULL
mediated	NULL
by	NULL
a	NULL
G	NULL
protein-coupled	NULL
pathway	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
on	NULL
induction	NULL
of	NULL
NF-B	NULL
and	NULL
activating	NULL
protein-1	NULL
binding	NULL
.	NULL

Both	NULL
molecules	NULL
enhanced	NULL
LPS-induced	NULL
NF-B	NULL
and	NULL
activating	NULL
protein-1	NULL
binding	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
the	NULL
capacity	NULL
of	NULL
intact	NULL
C3a	NULL
and	NULL
its	NULL
circulating	NULL
des-Arg	NULL
form	NULL
to	NULL
exert	NULL
immunmodulatory	NULL
effects	NULL
in	NULL
vitro	NULL
.	NULL

ctivation	NULL
and/or	NULL
dysregulation	NULL
of	NULL
the	NULL
complement	NULL
sys-A	NULL
tem	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
several	NULL
clinical	NULL
situations	NULL
,	NULL
such	NULL
as	NULL
sepsis	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
burn	NULL
injury	NULL
(	NULL
3	NULL
)	NULL
,	NULL
adult	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
autoimmune	NULL
diseases	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
blood	NULL
complement	NULL
system	NULL
via	NULL
either	NULL
the	NULL
classical	NULL
or	NULL
alternative	NULL
pathways	NULL
results	NULL
in	NULL
the	NULL
production	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
anaphylatoxins	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
C3a	NULL
,	NULL
C4a	NULL
,	NULL
and/or	NULL
C5a	NULL
(	NULL
6-8	NULL
)	NULL
.	NULL

C5a	NULL
,	NULL
the	NULL
best	NULL
characterized	NULL
of	NULL
the	NULL
anaphylatoxins	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
proinflammatory	NULL
mediator	NULL
that	NULL
induces	NULL
chemotactic	NULL
migration	NULL
,	NULL
increases	NULL
ox-idative	NULL
metabolism	NULL
and	NULL
the	NULL
release	NULL
of	NULL
lysosomal	NULL
enzymes	NULL
in	NULL
leu-kocytes	NULL
,	NULL
stimulates	NULL
the	NULL
release	NULL
of	NULL
numerous	NULL
inflammatory	NULL
mediators	NULL
including	NULL
histamine	NULL
and	NULL
cytokines	NULL
,	NULL
and	NULL
enhances	NULL
cellular	NULL
adhesion	NULL
(	NULL
8-12	NULL
)	NULL
.	NULL

C3a	NULL
also	NULL
possesses	NULL
proinflammatory	NULL
proper-ties	NULL
,	NULL
which	NULL
overlap	NULL
with	NULL
CSa	NULL
in	NULL
a	NULL
number	NULL
of	NULL
activities	NULL
.	NULL

C3a	NULL
is	NULL
spasmogenic	NULL
,	NULL
induces	NULL
the	NULL
release	NULL
of	NULL
PGE	NULL
,	NULL
from	NULL
human	NULL
macro-phages	NULL
,	NULL
induces	NULL
degranulation	NULL
and	NULL
chemotaxis	NULL
of	NULL
eosinophils	NULL
,	NULL
and	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
effective	NULL
chemotactic	NULL
mediators	NULL
yet	NULL
identified	NULL
for	NULL
human	NULL
mast	NULL
cells	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
we	NULL
demonstrated	NULL
a	NULL
direct	NULL
irmnmunmodulatory	NULL
effect	NULL
of	NULL
C3a	NULL
(	NULL
as	NULL
well	NULL
as	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
)	NULL
on	NULL
human	NULL
tonsil-derived	NULL
resting	NULL
B	NULL
lymphocytes	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
has	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
Received	NULL
for	NULL
publication	NULL
May	NULL
28	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
September	NULL
11	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
DE10992	NULL
and	NULL
AI41670	NULL
,	NULL
and	NULL
by	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
(	NULL
to	NULL
W.H.F	NULL
.	NULL
)	NULL

.	NULL

Blood	NULL
drawing	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
General	NULL
Clinical	NULL
Research	NULL
Center	NULL
facility	NULL
supported	NULL
by	NULL
National	NULL
Institute	NULL
of	NULL
Health	NULL
Grant	NULL
MO1IRRO0833	NULL
.	NULL

This	NULL
is	NULL
Publication	NULL
11653-IMM	NULL
from	NULL
the	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
.	NULL

Both	NULL
authors	NULL
equally	NULL
contributed	NULL
and	NULL
should	NULL
be	NULL
considered	NULL
as	NULL
co-first	NULL
authors	NULL
.	NULL

3	NULL
Current	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Toxicology	NULL
,	NULL
University	NULL
of	NULL
Wiirzburg	NULL
,	NULL
Versbacher	NULL
Str	NULL
.	NULL

9	NULL
,	NULL
97078	NULL
Wiirburg	NULL
,	NULL
Germany	NULL
.	NULL

*	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Tony	NULL
E.	NULL
Hugli	NULL
,	NULL
Department	NULL
of	NULL
Immunology-IMM18	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
10550	NULL
North	NULL
Torrey	NULL
Pines	NULL
Rd	NULL
.	NULL

,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92037	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
453-459.	NULL
been	NULL
shown	NULL
that	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
can	NULL
regulate	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
synthesis	NULL
in	NULL
LPS-stimulated	NULL
human	NULL
PBMC	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
immune	NULL
system	NULL
is	NULL
essential	NULL
for	NULL
protection	NULL
of	NULL
the	NULL
host	NULL
organism	NULL
from	NULL
microbial	NULL
invasion	NULL
,	NULL
tumorigenesis	NULL
,	NULL
and	NULL
environmental	NULL
insult	NULL
.	NULL

This	NULL
task	NULL
requires	NULL
concerted	NULL
actions	NULL
of	NULL
cellular	NULL
responses	NULL
that	NULL
are	NULL
regulated	NULL
by	NULL
a	NULL
complicated	NULL
network	NULL
of	NULL
cytokines	NULL
,	NULL
other	NULL
humoral	NULL
factors	NULL
,	NULL
and	NULL
cell-cell	NULL
interactions	NULL
.	NULL

Inflammatory	NULL
cytokines	NULL
,	NULL
including	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
IL-6	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
several	NULL
diseases	NULL
that	NULL
are	NULL
also	NULL
associated	NULL
with	NULL
complement	NULL
activation	NULL
.	NULL

Like	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
,	NULL
IL-6	NULL
is	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
produced	NULL
by	NULL
numerous	NULL
cell	NULL
types	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
LPS	NULL
,	NULL
platelet-derived	NULL
growth	NULL
fac-tor	NULL
,	NULL
and	NULL
the	NULL
cytokines	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
,	NULL
and	NULL
IL-2	NULL
(	NULL
18-21	NULL
)	NULL
.	NULL

IL-6	NULL
is	NULL
known	NULL
to	NULL
promote	NULL
differentiation	NULL
and	NULL
maturation	NULL
of	NULL
B	NULL
lympho-cytes	NULL
,	NULL
to	NULL
augment	NULL
T	NULL
lymphocyte	NULL
responses	NULL
,	NULL
to	NULL
stimulate	NULL
hemopoi-esis	NULL
,	NULL
and	NULL
to	NULL
induce	NULL
the	NULL
production	NULL
of	NULL
acute	NULL
phase	NULL
proteins	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Increased	NULL
serum	NULL
levels	NULL
of	NULL
IL-6	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
patients	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
diseases	NULL
,	NULL
including	NULL
acute	NULL
bacterial	NULL
infections	NULL
,	NULL
menin-gcoccal	NULL
septic	NULL
shock	NULL
,	NULL
systemic	NULL
lupus	NULL
erythematosus	NULL
,	NULL
Castleman	NULL
's	NULL
disease	NULL
,	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
and	NULL
AIDS	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
CS5a	NULL
on	NULL
cytokine	NULL
production	NULL
are	NULL
well	NULL
character-ized	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
demonstrated	NULL
that	NULL
C5a	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
gene	NULL
expression	NULL
and	NULL
protein	NULL
synthesis	NULL
for	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-8	NULL
(	NULL
10-12	NULL
,	NULL
26	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
characterization	NULL
of	NULL
C3a	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
cytokine	NULL
production	NULL
has	NULL
just	NULL
begun	NULL
.	NULL

It	NULL
is	NULL
the	NULL
purpose	NULL
of	NULL
the	NULL
present	NULL
study	NULL
to	NULL
further	NULL
explore	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
by	NULL
which	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
influence	NULL
immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
.	NULL

C3a	NULL
and	NULL
C3a	NULL
,	NULL
..	NULL
,	NULL
,	NULL
,	NULL
were	NULL
assessed	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
modulate	NULL
LPS-	NULL
and	NULL
IL-1B-induced	NULL
IL-6	NULL
production	NULL
in	NULL
human	NULL
PBMC	NULL
cultures	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
show	NULL
that	NULL
C3a	NULL
as	NULL
well	NULL
as	NULL
C3a_	NULL
,	NULL
_	NULL
,	NULL
a	NULL
,	NULL
,	NULL
are	NULL
potent	NULL
modulators	NULL
of	NULL
IL-6-specific	NULL
mRNA	NULL
and	NULL
protein	NULL
synthesis	NULL
in	NULL
human	NULL
PBMCs	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
C3a	NULL
and	NULL
C3aq	NULL
.	NULL

,	NULL
a	NULL
,	NULL
,	NULL
contribute	NULL
to	NULL
both	NULL
inflammation	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
immune	NULL
function	NULL
by	NULL
modulating	NULL
IL-6	NULL
,	NULL
which	NULL
possesses	NULL
potent	NULL
pleiotropic	NULL
functions	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
454	NULL
Materials	NULL
and	NULL
Methods	NULL
Reagents	NULL
All	NULL
chemicals	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
unless	NULL
indicated	NULL
otherwise	NULL
.	NULL

Ficoll	NULL
was	NULL
purchased	NULL
from	NULL
Pharmacia	NULL
(	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

RPMI	NULL
medium	NULL
was	NULL
obtained	NULL
from	NULL
BioWhittaker	NULL
(	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

IL-16	NULL
was	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Capture	NULL
and	NULL
detection	NULL
Abs	NULL
for	NULL
ELISA	NULL
were	NULL
obtained	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
synthetic	NULL
C3a	NULL
analogue	NULL
peptide	NULL
71/53	NULL
(	NULL
13	NULL
,	NULL
30	NULL
)	NULL
(	NULL
WWGKKYRASKLGLAR	NULL
)	NULL
was	NULL
synthesized	NULL
,	NULL
and	NULL
both	NULL
purity	NULL
and	NULL
sequence	NULL
were	NULL
confirmed	NULL
in	NULL
the	NULL
protein/nucleotide	NULL
core	NULL
facilities	NULL
of	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
.	NULL

The	NULL
human	NULL
IL-6	NULL
cDNA	NULL
probe	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Edward	NULL
Morgan	NULL
(	NULL
The	NULL
La	NULL
Jolla	NULL
Cancer	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
human	NULL
C3a	NULL
Human	NULL
C3a	NULL
was	NULL
purified	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
C3a	NULL
was	NULL
determined	NULL
by	NULL
amino	NULL
acid	NULL
analysis	NULL
.	NULL

Based	NULL
on	NULL
tracer	NULL
experiments	NULL
with	NULL
[	NULL
'	NULL
>	NULL
°IJCSa	NULL
,	NULL
contamination	NULL
of	NULL
the	NULL
C3a	NULL
preparation	NULL
with	NULL
C5a	NULL
was	NULL
<	NULL
0.0017	NULL
%	NULL
.	NULL

By	NULL
using	NULL
the	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
BioWhittaker	NULL
)	NULL
,	NULL
LPS	NULL
contamination	NULL
of	NULL
C3a	NULL
,	NULL
C3a	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
,	NULL
or	NULL
the	NULL
C3a	NULL
analogue	NULL
71/53	NULL
was	NULL
not	NULL
detectable	NULL
.	NULL

was	NULL
obtained	NULL
by	NULL
treating	NULL
the	NULL
highly	NULL
purified	NULL
C3a	NULL
with	NULL
1	NULL
%	NULL
(	NULL
w/w	NULL
)	NULL
carboxypeptidase	NULL
B	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
amonium	NULL
bicarbonate	NULL
buffer	NULL
at	NULL
pH	NULL
8.0	NULL
.	NULL

The	NULL
conversion	NULL
of	NULL
C3a	NULL
to	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
@	NULL
,	NULL
,	NULL
was	NULL
confirmed	NULL
by	NULL
mass	NULL
spectometry	NULL
,	NULL
demonstrating	NULL
homogeneous	NULL
peaks	NULL
of	NULL
9093	NULL
and	NULL
8933	NULL
mass	NULL
units	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
C3a	NULL
and	NULL
C3aq	NULL
.	NULL

,	NULL
a	NULL
,	NULL
,	NULL
(	NULL
mass	NULL
spectometry	NULL
core	NULL
facilities	NULL
of	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
PBMCs	NULL
PBMCs	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
human	NULL
donors	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
blood	NULL
was	NULL
drawn	NULL
into	NULL
EDTA-containing	NULL
syringes	NULL
to	NULL
achieve	NULL
a	NULL
final	NULL
EDTA	NULL
concentration	NULL
of	NULL
10	NULL
mM	NULL
.	NULL

Thirty-five	NULL
milliliters	NULL
of	NULL
whole	NULL
blood	NULL
was	NULL
layered	NULL
over	NULL
15	NULL
ml	NULL
of	NULL
Ficoll-Hypaque	NULL
(	NULL
Phar-macia	NULL
)	NULL
and	NULL
centrifuged	NULL
at	NULL
600	NULL
X	NULL
g	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
mononuclear	NULL
cell	NULL
layer	NULL
was	NULL
recovered	NULL
and	NULL
washed	NULL
twice	NULL
in	NULL
Earle	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
containing	NULL
10	NULL
mM	NULL
MOPS	NULL
at	NULL
pH	NULL
7.3	NULL
.	NULL

The	NULL
final	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
ug/tal	NULL
streptomycin	NULL
(	NULL
Bio-Whittaker	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
condition	NULL
For	NULL
induction	NULL
of	NULL
IL-6	NULL
protein	NULL
,	NULL
triplicate	NULL
cultures	NULL
were	NULL
established	NULL
in	NULL
96-well	NULL
microculture	NULL
plates	NULL
(	NULL
Corning	NULL
,	NULL
NY	NULL
)	NULL
;	NULL
each	NULL
well	NULL
contained	NULL
5	NULL
X	NULL
10°	NULL
PBMCs	NULL
.	NULL

LPS	NULL
from	NULL
Escherichia	NULL
coli	NULL
(	NULL
strain	NULL
ECOSSB5	NULL
;	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
500	NULL
ng/ml	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
C3a	NULL
or	NULL
C324	NULL
,	NULL
,	NULL
arg	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
then	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
collected	NULL
after	NULL
18	NULL
h	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
until	NULL
assayed	NULL
for	NULL
IL-6	NULL
.	NULL

For	NULL
isolation	NULL
of	NULL
total	NULL
RNA	NULL
and	NULL
extracts	NULL
of	NULL
nuclear	NULL
proteins	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
culture	NULL
medium	NULL
in	NULL
six-well	NULL
plates	NULL
and	NULL
incubated	NULL
for	NULL
various	NULL
times	NULL
under	NULL
the	NULL
conditions	NULL
described	NULL
above	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blotting	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
with	NULL
TRIzol	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaith-ersburg	NULL
,	NULL
MD	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Eight	NULL
micro-grams	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
in	NULL
agarose	NULL
gels	NULL
containing	NULL
0.22	NULL
M	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
to	NULL
the	NULL
Hybond-N	NULL
Plus	NULL
membranes	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
by	NULL
diffusion	NULL
.	NULL

The	NULL
probe	NULL
for	NULL
human	NULL
B-actin	NULL
was	NULL
generated	NULL
by	NULL
RT-PCR	NULL
,	NULL
using	NULL
human	NULL
B-actin	NULL
specific	NULL
primers	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
amplified	NULL
product	NULL
reflects	NULL
the	NULL
human	NULL
B-actin	NULL
mRNA	NULL
,	NULL
it	NULL
was	NULL
eluted	NULL
from	NULL
the	NULL
gel	NULL
and	NULL
cloned	NULL
in	NULL
the	NULL
TA	NULL
cloning	NULL
vector	NULL
pCRTM2.1	NULL
.	NULL

(	NULL
Invitrogen	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
,	NULL
and	NULL
the	NULL
nucleotide	NULL
sequence	NULL
was	NULL
determined	NULL
.	NULL

Sequencing	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
protein/nucleotide	NULL
core	NULL
facilities	NULL
of	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
.	NULL

The	NULL
sequence	NULL
obtained	NULL
was	NULL
identical	NULL
with	NULL
those	NULL
published	NULL
.	NULL

The	NULL
human	NULL
IL-6	NULL
cDNA	NULL
probe	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Edward	NULL
Morgan	NULL
.	NULL

For	NULL
hybridization	NULL
,	NULL
the	NULL
fragments	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-*P	NULL
]	NULL
dCTP	NULL
to	NULL
a	NULL
sp	NULL
.	NULL

act	NULL
.	NULL

of	NULL
>	NULL
2	NULL
X	NULL
10°	NULL
cpm/ug	NULL
DNA	NULL
using	NULL
a	NULL
random	NULL
primer	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
in	NULL
QuikHyb	NULL
solution	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
68°C	NULL
for	NULL
20	NULL
min	NULL
and	NULL
further	NULL
hybridized	NULL
with	NULL
the	NULL
labeled	NULL
probes	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cpm/ml	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
the	NULL
same	NULL
temperature	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
2X	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
followed	NULL
by	NULL
another	NULL
wash	NULL
with	NULL
0.1X	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
at	NULL
60°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
exposed	NULL
to	NULL
a	NULL
PhosphorImager	NULL
screen	NULL
and	NULL
analyzed	NULL
by	NULL
a	NULL
PhosphorImaging	NULL
system	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

REGULATION	NULL
OF	NULL
IL-6	NULL
SYNTHESIS	NULL
BY	NULL
C3a	NULL
Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
modified	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
PBMC	NULL
(	NULL
5	NULL
%	NULL
10°/sample	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
different	NULL
agent	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
,	NULL
after	NULL
which	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
harvested	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
0.4	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
each	NULL
of	NULL
EDTA	NULL
and	NULL
EGTA	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
)	NULL
.	NULL

After	NULL
10	NULL
min	NULL
,	NULL
23	NULL
ul	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
and	NULL
mixed	NULL
for	NULL
2	NULL
s.	NULL
Nuclei	NULL
were	NULL
separated	NULL
from	NULL
cytosol	NULL
by	NULL
cen-trifugation	NULL
at	NULL
13,000	NULL
X	NULL
g	NULL
for	NULL
20	NULL
s	NULL
and	NULL
were	NULL
resuspended	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
)	NULL
.	NULL

After	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
lysates	NULL
were	NULL
separated	NULL
by	NULL
centrifuga-tion	NULL
at	NULL
13,000	NULL
X	NULL
g	NULL
for	NULL
40	NULL
s	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
containing	NULL
nuclear	NULL
proteins	NULL
were	NULL
transferred	NULL
into	NULL
new	NULL
vials	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
measured	NULL
using	NULL
a	NULL
protein	NULL
dye	NULL
reagent	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
BSA	NULL
as	NULL
stan-dard	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
diluted	NULL
to	NULL
equal	NULL
concentrations	NULL
in	NULL
buffer	NULL
B	NULL
.	NULL

Samples	NULL
were	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
``	NULL
EMSAs	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
jg	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
added	NULL
to	NULL
12	NULL
ul	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
5	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.4	NULL
mg/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
0.1	NULL
mg/ml	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Approximately	NULL
40	NULL
fmol	NULL
of	NULL
**P-labeled	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Stratagene	NULL
)	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
continued	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
.	NULL

For	NULL
reactions	NULL
involving	NULL
competitor	NULL
oligonucleotides	NULL
,	NULL
the	NULL
unlabeled	NULL
and	NULL
labeled	NULL
probes	NULL
were	NULL
added	NULL
simultaneously	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
on	NULL
5	NULL
%	NULL
acrylamide	NULL
gel	NULL
,	NULL
made	NULL
with	NULL
buffers	NULL
containing	NULL
50	NULL
mM	NULL
Tris	NULL
borate	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
.	NULL

After	NULL
pre-electrophoresis	NULL
for	NULL
1	NULL
h	NULL
at	NULL
8	NULL
V/cm	NULL
,	NULL
samples	NULL
were	NULL
applied	NULL
,	NULL
and	NULL
electrophoresis	NULL
was	NULL
conducted	NULL
at	NULL
the	NULL
same	NULL
voltage	NULL
for	NULL
1.5-2	NULL
h.	NULL
The	NULL
gels	NULL
were	NULL
transfered	NULL
to	NULL
Whatman	NULL
paper	NULL
(	NULL
Clifton	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
dried	NULL
,	NULL
exposed	NULL
to	NULL
a	NULL
PhosphorImager	NULL
screen	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
a	NULL
PhosphorImaging	NULL
system	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
cytokine	NULL
production	NULL
by	NULL
human	NULL
PBMC	NULL
IL-6	NULL
production	NULL
in	NULL
supernatants	NULL
from	NULL
human	NULL
PBMC	NULL
cultures	NULL
was	NULL
measured	NULL
by	NULL
sandwich	NULL
ELISA	NULL
using	NULL
paired	NULL
mAb	NULL
(	NULL
PharMingen	NULL
)	NULL
,	NULL
following	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

Results	NULL
C3a	NULL
and	NULL
C3aj	NULL
...	NULL
,	NULL
,	NULL
enhance	NULL
LPS-	NULL
and	NULL
IL-1B-	NULL
induced	NULL
IL-6	NULL
release	NULL
from	NULL
human	NULL
PBMCs	NULL
Recently	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
demonstrated	NULL
immunmodulatory	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
.~	NULL
,	NULL
,	NULL
on	NULL
cytokine	NULL
synthesis	NULL
in	NULL
human	NULL
PBMCs	NULL
and	NULL
human	NULL
tonsil-derived	NULL
B	NULL
lymphocytes	NULL
(	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
C3a	NULL
and	NULL
can	NULL
modulate	NULL
the	NULL
production	NULL
of	NULL
a	NULL
related	NULL
cytokine	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
IL-6	NULL
,	NULL
under	NULL
various	NULL
experimental	NULL
conditions	NULL
.	NULL

Unstimulated	NULL
human	NULL
PBMCs	NULL
or	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
1	NULL
uM	NULL
C3a	NULL
or	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
alone	NULL
did	NULL
not	NULL
release	NULL
detectable	NULL
levels	NULL
of	NULL
IL-6	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
at	NULL
concentrations	NULL
from	NULL
1	NULL
uM	NULL
to	NULL
10	NULL
nM	NULL
,	NULL
both	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
enhanced	NULL
LPS-induced	NULL
IL-6	NULL
release	NULL
from	NULL
human	NULL
PBMCs	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

At	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
M	NULL
,	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
Significantly	NULL
increased	NULL
IL-6	NULL
levels	NULL
in	NULL
culture	NULL
supernatants	NULL
of	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

by	NULL
400	NULL
+	NULL
30	NULL
and	NULL
328	NULL
+	NULL
19	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

At	NULL
a	NULL
concentration	NULL
at	NULL
or	NULL
below	NULL
10	NULL
nM	NULL
,	NULL
neither	NULL
C3a	NULL
nor	NULL
m-duced	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
IL-6	NULL
.	NULL

We	NULL
next	NULL
asked	NULL
whether	NULL
the	NULL
observed	NULL
increase	NULL
in	NULL
IL-6	NULL
production	NULL
by	NULL
C3a	NULL
and	NULL
18	NULL
Specific	NULL
for	NULL
LPS	NULL
stimulation	NULL
or	NULL
whether	NULL
activation	NULL
of	NULL
cells	NULL
by	NULL
other	NULL
stimuli	NULL
(	NULL
ie	NULL
.	NULL

,	NULL
IL-1B	NULL
(	NULL
25	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
C3a	NULL
or	NULL
arg	NULL
would	NULL
also	NULL
result	NULL
in	NULL
enhanced	NULL
IL-6	NULL
release	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
,	NULL
both	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
enhanced	NULL
IL-1	NULL
B-induced	NULL
IL-6	NULL
release	NULL
in	NULL
PBMCs	NULL
.	NULL

At	NULL
the	NULL
highest	NULL
concentrations	NULL
of	NULL
C3a	NULL
and	NULL
C3	NULL
@	NULL
4csarg	NULL
(	NULL
1	NULL
M	NULL
)	NULL
the	NULL
increases	NULL
in	NULL
IL-1	NULL
B-induced	NULL
IL-6	NULL
release	NULL
were	NULL
5	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
PTX	NULL
,	NULL
pertussis	NULL
toxin	NULL
;	NULL
AP-1	NULL
,	NULL
activating	NULL
protein-1	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
€	NULL
&	NULL
5	NULL
.	NULL

©	NULL
=	NULL
!	NULL

LPS	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
C3a	NULL
[	NULL
nM	NULL
]	NULL
_	NULL
-	NULL
1000	NULL
1000	NULL
500	NULL
100	NULL
10	NULL
80	NULL
70	NULL
60	NULL
-|	NULL
IL-6	NULL
[	NULL
ng/ml	NULL
]	NULL
p	NULL
T	NULL
LPS	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
(	NULL
nm	NULL
]	NULL
1000	NULL
-	NULL
1000	NULL
500	NULL
100	NULL
10	NULL
160	NULL
140	NULL
120	NULL
100	NULL
so	NULL
eo	NULL
40	NULL
IL-6	NULL
[	NULL
ng/ml	NULL
]	NULL
IL1B	NULL
-	NULL
+	NULL
+	NULL
+	NULL
CS3a	NULL
[	NULL
nM	NULL
]	NULL
-	NULL
1000	NULL
-	NULL
1000	NULL
500	NULL
100	NULL
10	NULL
160	NULL
140	NULL
120	NULL
100	NULL
80	NULL
IL-6	NULL
[	NULL
ng/ml	NULL
]	NULL
N	NULL
R	NULL
Q	NULL
o	NULL
o	NULL
o	NULL
1	NULL
1	NULL
1	NULL
0	NULL
IL-1B	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
c3a	NULL
``	NULL
°	NULL
``	NULL
``	NULL
I	NULL
[	NULL
nM	NULL
]	NULL
1000	NULL
-	NULL
1000	NULL
500	NULL
100	NULL
10	NULL
FIGURE	NULL
1	NULL
.	NULL

Effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a,4	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
on	NULL
IL-6	NULL
production	NULL
by	NULL
human	NULL
PBMCs	NULL
.	NULL

PBMCs	NULL
were	NULL
cultured	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
and	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
;	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
IL-1	NULL
(	NULL
25	NULL
ng/ml	NULL
;	NULL
C	NULL
and	NULL
1D	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
concentrations	NULL
of	NULL
C3a	NULL
or	NULL
C3a	NULL
,	NULL
,	NULL
.	NULL

,	NULL
\	NULL
,	NULL
,	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
after	NULL
18	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

Levels	NULL
of	NULL
IL-6	NULL
were	NULL
determined	NULL
by	NULL
cytokine-specific	NULL
ELISA	NULL
.	NULL

Differences	NULL
in	NULL
IL-6	NULL
levels	NULL
were	NULL
analyzed	NULL
by	NULL
Student	NULL
's	NULL
f	NULL
test	NULL
(	NULL
the	NULL
asterisk	NULL
indicates	NULL
p	NULL
<	NULL
0.02	NULL
)	NULL
.	NULL

n.d.	NULL
,	NULL
not	NULL
detectable	NULL
.	NULL

The	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
six	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

455	NULL
160	NULL
140	NULL
120	NULL
100	NULL
IL-6	NULL
[	NULL
ng/ml	NULL
]	NULL
a	NULL
®	NULL
o	NULL
o	NULL
1	NULL
I	NULL
LPS	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
71/53	NULL
[	NULL
uM	NULL
]	NULL
_	NULL
-	NULL
10	NULL
-	NULL
10	NULL
5°	NULL
25	NULL
1	NULL
FIGURE	NULL
2	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
synthetic	NULL
analogue	NULL
C3a	NULL
peptide	NULL
71/53	NULL
(	NULL
peptide	NULL
sequence	NULL
:	NULL
WWGKKYRASKLGLAR	NULL
)	NULL
on	NULL
IL-6	NULL
production	NULL
by	NULL
human	NULL
PBMCs	NULL
.	NULL

PBMCs	NULL
were	NULL
cultured	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
and	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
concentrations	NULL
of	NULL
71/53	NULL
peptide	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
after	NULL
18	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

Levels	NULL
of	NULL
IL-6	NULL
were	NULL
determined	NULL
by	NULL
cytokine-specific	NULL
ELISA	NULL
.	NULL

Differences	NULL
in	NULL
IL-6	NULL
levels	NULL
were	NULL
analyzed	NULL
by	NULL
Student	NULL
's	NULL
f	NULL
test	NULL
(	NULL
the	NULL
asterisk	NULL
indicates	NULL
p	NULL
<	NULL
0.02	NULL
)	NULL
.	NULL

n.d.	NULL
,	NULL
not	NULL
detectable	NULL
.	NULL

The	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

310	NULL
+	NULL
40	NULL
and	NULL
293	NULL
+	NULL
38	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

Surprisingly	NULL
,	NULL
but	NULL
in	NULL
agreement	NULL
with	NULL
former	NULL
studies	NULL
,	NULL
C3a	NULL
,	NULL
,	NULL
.	NULL

,	NULL
\	NULL
,	NULL
,	NULL
was	NULL
almost	NULL
as	NULL
effective	NULL
as	NULL
C3a	NULL
itself	NULL
(	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
500	NULL
nM	NULL
an	NULL
apparent	NULL
difference	NULL
was	NULL
observed	NULL
between	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
that	NULL
was	NULL
not	NULL
observed	NULL
at	NULL
other	NULL
concentrations	NULL
.	NULL

To	NULL
prove	NULL
that	NULL
the	NULL
observed	NULL
increases	NULL
in	NULL
IL-6	NULL
production	NULL
were	NULL
specific	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
and	NULL
not	NULL
due	NULL
to	NULL
contaminants	NULL
in	NULL
the	NULL
C3a	NULL
preparations	NULL
used	NULL
in	NULL
our	NULL
experiments	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
synthetic	NULL
C3a	NULL
analogue	NULL
peptide	NULL
71/53	NULL
(	NULL
peptide	NULL
sequence	NULL
WWGKKYRASKLGLAR	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
peptide	NULL
exhibits	NULL
the	NULL
same	NULL
biological	NULL
activities	NULL
as	NULL
native	NULL
C3a	NULL
(	NULL
13	NULL
,	NULL
30	NULL
)	NULL
.	NULL

PBMCs	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
and	NULL
different	NULL
concentrations	NULL
of	NULL
C3a	NULL
analogue	NULL
71/53	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
peptide	NULL
analogue	NULL
was	NULL
also	NULL
found	NULL
to	NULL
increase	NULL
LPS-induced	NULL
IL-6	NULL
production	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
C3a	NULL
analogue	NULL
peptide	NULL
required	NULL
to	NULL
produce	NULL
approximately	NULL
the	NULL
same	NULL
enhancement	NULL
was	NULL
5-10	NULL
times	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
native	NULL
human	NULL
C3a	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
former	NULL
studies	NULL
of	NULL
this	NULL
peptide	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
observed	NULL
enhancing	NULL
effects	NULL
of	NULL
C3a	NULL
on	NULL
IL-6	NULL
production	NULL
in	NULL
PBMCs	NULL
are	NULL
specific	NULL
effects	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

C3a	NULL
and	NULL
C3aj..a	NULL
,	NULL
,	NULL
enhance	NULL
LPS-induced	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
in	NULL
human	NULL
PBMCs	NULL
To	NULL
investigate	NULL
whether	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a,4	NULL
,	NULL
,4	NULL
,	NULL
,	NULL
on	NULL
IL-6	NULL
are	NULL
accompanied	NULL
by	NULL
increased	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
,	NULL
PBMCs	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
plus	NULL
1	NULL
wM	NULL
C3a	NULL
or	NULL
and	NULL
RNA	NULL
was	NULL
prepared	NULL
for	NULL
Northern	NULL
blotting	NULL
.	NULL

A	NULL
time	NULL
course	NULL
from	NULL
0-24	NULL
h	NULL
demonstrated	NULL
that	NULL
neither	NULL
C3a	NULL
nor	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
alone	NULL
can	NULL
induce	NULL
IL-6	NULL
mRNA	NULL
in	NULL
PBMCs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
both	NULL
LPS	NULL
plus	NULL
C3a	NULL
or	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
,	NULL
we	NULL
found	NULL
an	NULL
increase	NULL
in	NULL
IL-6	NULL
mRNA	NULL
at	NULL
3	NULL
h	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Standardization	NULL
of	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
to	NULL
B-actin	NULL
mRNA	NULL
levels	NULL
revealed	NULL
that	NULL
IL-6	NULL
mRNA	NULL
increased	NULL
by	NULL
60	NULL
and	NULL
63	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
costimulated	NULL
with	NULL
LPS	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
indomethacin	NULL
on	NULL
C3a-	NULL
and	NULL
-mediated	NULL
increases	NULL
in	NULL
IL-6	NULL
production	NULL
in	NULL
LPS-	NULL
or	NULL
IL-1B-stimulated	NULL
PBMCs	NULL
A	NULL
previous	NULL
study	NULL
demonstrated	NULL
that	NULL
C3a	NULL
stimulates	NULL
PGE	NULL
,	NULL
production	NULL
in	NULL
human	NULL
macrophages	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
456	NULL
la	NULL
1b	NULL
Ic	NULL
IL-6	NULL
-	NULL
»	NULL
same	NULL
GBB	NULL
was	NULL
-	NULL
CHB	NULL
Bacin	NULL
-	NULL
|	NULL
@	NULL
@	NULL
@	NULL
)	NULL
.	NULL

«	NULL
wes	NULL
.	NULL

cna	NULL
»	NULL
1d	NULL
le	NULL
1f	NULL
LPS	NULL
-o-	NULL
-	NULL
+o	NULL
+	NULL
+o	NULL
+	NULL
C3a	NULL
-o	NULL
40	NULL
-	NULL
-	NULL
0+	NULL
-	NULL
>	NULL
C3a	NULL
desArg	NULL
-o	NULL
-	NULL
+	NULL
-	NULL
>	NULL
-	NULL
-	NULL
+	NULL
FIGURE	NULL
3	NULL
.	NULL

Effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
on	NULL
IL-6	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
PBMCs	NULL
.	NULL

Northern	NULL
blot	NULL
with	NULL
total	NULL
RNA	NULL
(	NULL
8	NULL
pug/lane	NULL
)	NULL
isolated	NULL
from	NULL
PBMCs	NULL
(	NULL
5	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
treated	NULL
as	NULL
indicated	NULL
below	NULL
.	NULL

7a	NULL
,	NULL
Unstimulated	NULL
cells	NULL
,	NULL
cells	NULL
stimulated	NULL
with	NULL
C3a	NULL
(	NULL
1	NULL
M	NULL
)	NULL
or	NULL
(	NULL
1	NULL
LM	NULL
)	NULL
;	NULL
/b	NULL
,	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
C3a	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
,	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
C3	NULL
@	NULL
4	NULL
,	NULL
,	NULL
arg	NULL
(	NULL
1	NULL
M	NULL
)	NULL
;	NULL
14-If	NULL
,	NULL
B-actin	NULL
controls	NULL
.	NULL

These	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

that	NULL
PGE	NULL
,	NULL
leads	NULL
to	NULL
increased	NULL
intracellular	NULL
cAMP	NULL
levels	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Since	NULL
both	NULL
PGE	NULL
,	NULL
and	NULL
cAMP	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
we	NULL
addressed	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
endogenous	NULL
PGE	NULL
,	NULL
contributes	NULL
to	NULL
and/or	NULL
influences	NULL
these	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
On	NULL
IL-6	NULL
regulation	NULL
in	NULL
LPS-	NULL
or	NULL
IL-1-stimulated	NULL
PBMCs	NULL
.	NULL

Indomethacin	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
pg/ml	NULL
totally	NULL
inhib-	NULL
120	NULL
®	NULL
-	NULL
indomethacin	NULL
A	NULL
{	NULL
pg	NULL
|Q	NULL
+	NULL
Indomethacin	NULL
_	NULL
,	NULL
807	NULL
E	NULL
I	NULL
2	NULL
eo-©	NULL
--	NULL
407	NULL
20	NULL
{	NULL
0	NULL
LPS	NULL
LPS	NULL
LPS	NULL
C3a	NULL
c3adesArg	NULL
200	NULL
{	NULL
go	NULL
|	NULL
]	NULL
®	NULL
-	NULL
Indomethacin	NULL
Q	NULL
+	NULL
Indomethacin	NULL
B	NULL
160	NULL
140	NULL
120	NULL
100	NULL
{	NULL
80	NULL
{	NULL
60	NULL
40	NULL
20	NULL
0	NULL
IL-18	NULL
IL-1	NULL
$	NULL
C3a	NULL
Cs3atdesArg	NULL
FIGURE	NULL
4	NULL
.	NULL

Influence	NULL
of	NULL
indomethacin	NULL
on	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C324	NULL
,	NULL
a.	NULL
,	NULL
on	NULL
IL-6	NULL
production	NULL
by	NULL
human	NULL
PBMCs	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
at	NULL
5	NULL
10°	NULL
cells/ml	NULL
,	NULL
prestimulated	NULL
with	NULL
indomethacin	NULL
(	NULL
1	NULL
pg/m	NULL
!	NULL

1	NULL
)	NULL
for	NULL
0.5	NULL
h	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
,	NULL
and	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
;	NULL
A	NULL
)	NULL
or	NULL
IL-1	NULL
(	NULL
B	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
C3a	NULL
or	NULL
C3a	NULL
,	NULL
,	NULL
..	NULL
,	NULL
\	NULL
,	NULL
,	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
after	NULL
18	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

Levels	NULL
of	NULL
IL-6	NULL
were	NULL
determined	NULL
by	NULL
cytokine-specific	NULL
ELISA	NULL
.	NULL

The	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

IL-6	NULL
[	NULL
ng/ml	NULL
]	NULL
REGULATION	NULL
OF	NULL
IL-6	NULL
SYNTHESIS	NULL
BY	NULL
C3a	NULL
<	NULL
300	NULL
E	NULL
m	NULL
-P	NULL
a	NULL
0	NULL
€	NULL
250	NULL
C	NULL
+	NULL
PTX	NULL
8	NULL
#	NULL
200	NULL
_I	NULL
©	NULL
150	NULL
0	NULL
©	NULL
=	NULL
100	NULL
3	NULL
9	NULL
*	NULL
2	NULL
o	NULL
LPS	NULL
LPS	NULL
C3a	NULL
11°	NULL
150	NULL
8	NULL
-r	NULL
B	NULL
0	NULL
€	NULL
]	NULL
+	NULL
PTX	NULL
0	NULL
3	NULL
-	NULL
100	NULL
5	NULL
>	NULL
0	NULL
&	NULL
©	NULL
<	NULL
50	NULL
0	NULL
&	NULL
*	NULL
5	NULL
|—I—|	NULL
*	NULL
2	NULL
o	NULL
£	NULL
IL~1B	NULL
IL-1B	NULL
C3a	NULL
FIGURE	NULL
5	NULL
.	NULL

Influence	NULL
of	NULL
PTX	NULL
on	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C3	NULL
@	NULL
4.,4	NULL
,	NULL
,	NULL
OD	NULL
IL-6	NULL
release	NULL
by	NULL
human	NULL
PBMCs	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
,	NULL
pretreated	NULL
with	NULL
PTX	NULL
(	NULL
500	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
3	NULL
h	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
,	NULL
and	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
;	NULL
A	NULL
)	NULL
or	NULL
IL-1	NULL
(	NULL
B	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
C3a	NULL
or	NULL
C3aq	NULL
.	NULL

,	NULL
A.	NULL
,	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
after	NULL
18	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

Levels	NULL
of	NULL
IL-6	NULL
were	NULL
determined	NULL
by	NULL
cytokine-specific	NULL
ELISA	NULL
.	NULL

Differences	NULL
in	NULL
IL-6	NULL
levels	NULL
were	NULL
analyzed	NULL
by	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
(	NULL
the	NULL
asterisk	NULL
indicates	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

The	NULL
data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

ited	NULL
the	NULL
production	NULL
of	NULL
PGE	NULL
,	NULL
in	NULL
PBMC	NULL
cultures	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m1	NULL
)	NULL
,	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
,	NULL
or	NULL
LPS	NULL
in	NULL
combination	NULL
with	NULL
C3a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
indomethacin	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IL-6	NULL
release	NULL
in	NULL
human	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
LPS	NULL
or	NULL
IL-1	NULL
3	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
C3a	NULL
or	NULL
C3aq..a	NULL
,	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Indomethacin	NULL
itself	NULL
did	NULL
not	NULL
induce	NULL
IL-6	NULL
release	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
observed	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C32,4	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
are	NULL
NOt	NULL
mediated	NULL
via	NULL
the	NULL
production	NULL
of	NULL
endogenous	NULL
PGE	NULL
.	NULL

C3a-	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
-	NULL
mediated	NULL
increases	NULL
in	NULL
IL-6	NULL
production	NULL
in	NULL
LPS-	NULL
or	NULL
IL-1B-stimulated	NULL
PBMCs	NULL
are	NULL
pertussis	NULL
toxin	NULL
(	NULL
PTX	NULL
)	NULL
sensitive	NULL
C3a	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
receptor	NULL
that	NULL
is	NULL
functionally	NULL
coupled	NULL
to	NULL
G	NULL
proteins	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
C3a	NULL
receptor	NULL
confirmed	NULL
that	NULL
it	NULL
possesses	NULL
a	NULL
structure	NULL
typical	NULL
of	NULL
a	NULL
G	NULL
protein-coupled	NULL
receptor	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
addressed	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
the	NULL
observed	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
_.	NULL
,	NULL
,	NULL
,	NULL
are	NULL
subject	NULL
to	NULL
inhibition	NULL
by	NULL
PTX	NULL
.	NULL

Pretreatment	NULL
of	NULL
cells	NULL
with	NULL
PTX	NULL
is	NULL
known	NULL
to	NULL
interfere	NULL
with	NULL
signals	NULL
mediated	NULL
through	NULL
G	NULL
;	NULL
-type	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
pro-teins	NULL
.	NULL

Our	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
indicate	NULL
that	NULL
pretreatment	NULL
of	NULL
PBMCs	NULL
with	NULL
PTX	NULL
for	NULL
3	NULL
h	NULL
almost	NULL
completely	NULL
abolished	NULL
C3a-	NULL
or	NULL
C3a_	NULL
_	NULL
a	NULL
,	NULL
,	NULL
-	NULL
mediated	NULL
enhancement	NULL
of	NULL
IL-6	NULL
release	NULL
in	NULL
LPS-	NULL
or	NULL
IL-1B-stimulated	NULL
PBMCs	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
the	NULL
observed	NULL
inhibitory	NULL
effect	NULL
of	NULL
PTX	NULL
could	NULL
also	NULL
be	NULL
demonstrated	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
pretreatment	NULL
of	NULL
cells	NULL
with	NULL
PTX	NULL
blocked	NULL
C3a-	NULL
as	NULL
well	NULL
as	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
-mediated	NULL
increases	NULL
in	NULL
IL-6	NULL
mRNA	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
mediate	NULL
their	NULL
effects	NULL
via	NULL
a	NULL
specific	NULL
G	NULL
protein-coupled	NULL
pathway	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
IL-6	NULL
--	NULL
»	NULL
«	NULL
ma	NULL
tae	NULL
as	NULL
as	NULL
B-actin	NULL
-	NULL
>	NULL
|	NULL
_	NULL
_	NULL
car	NULL
ems	NULL
LPS	NULL
+o	NULL
+	NULL
+	NULL
+	NULL
C3a	NULL
Se	NULL
a	NULL
-	NULL
>	NULL
_-C3a	NULL
desArg	NULL
-o-	NULL
-	NULL
+	NULL
FIGURE	NULL
6	NULL
.	NULL

Influence	NULL
of	NULL
PTX	NULL
on	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
up-regulation	NULL
of	NULL
IL-6	NULL
mRNA	NULL
expression	NULL
by	NULL
human	NULL
PBMCs	NULL
.	NULL

A	NULL
Northern	NULL
blot	NULL
with	NULL
total	NULL
RNA	NULL
(	NULL
8	NULL
pug/lane	NULL
)	NULL
isolated	NULL
after	NULL
treatment	NULL
of	NULL
PBMCs	NULL
(	NULL
5	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
below	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

Cells	NULL
were	NULL
prestimulated	NULL
with	NULL
PTX	NULL
(	NULL
500	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
3	NULL
h	NULL
and	NULL
thereafter	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
C3a	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
or	NULL
C3ag..4	NULL
,	NULL
,	NULL
(	NULL
1	NULL
LM	NULL
)	NULL
for	NULL
3	NULL
h.	NULL
B-Actin	NULL
was	NULL
used	NULL
as	NULL
the	NULL
control	NULL
.	NULL

These	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
activating	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
by	NULL
C3a	NULL
and	NULL
Previous	NULL
reports	NULL
indicated	NULL
that	NULL
the	NULL
NF-B	NULL
binding	NULL
site	NULL
located	NULL
between	NULL
positions	NULL
-72	NULL
and	NULL
-63	NULL
on	NULL
the	NULL
IL-6	NULL
gene	NULL
is	NULL
important	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-6	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Another	NULL
important	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IL-6	NULL
transcription	NULL
is	NULL
AP-1	NULL
,	NULL
with	NULL
a	NULL
consensus	NULL
binding	NULL
sequence	NULL
found	NULL
at	NULL
position	NULL
-283	NULL
to	NULL
-277	NULL
in	NULL
the	NULL
IL-6	NULL
promoter	NULL
(	NULL
36	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
observed	NULL
enhanced	NULL
responses	NULL
seen	NULL
after	NULL
costimulation	NULL
of	NULL
PBMCs	NULL
with	NULL
LPS	NULL
and	NULL
C3a	NULL
were	NULL
related	NULL
to	NULL
a	NULL
different	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
these	NULL
factors	NULL
using	NULL
EMSAs	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
treatment	NULL
of	NULL
PBMCs	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

alone	NULL
caused	NULL
induction	NULL
of	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
binding	NULL
activities	NULL
.	NULL

However	NULL
,	NULL
costimulation	NULL
of	NULL
PBMCs	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
C3a	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
additional	NULL
increase	NULL
in	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
C3a	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
alone	NULL
showed	NULL
increased	NULL
DNA	NULL
binding	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
in	NULL
untreated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
these	NULL
DNA-protein	NULL
interactions	NULL
were	NULL
specific	NULL
,	NULL
we	NULL
performed	NULL
competition	NULL
experiments	NULL
with	NULL
unlabeled	NULL
oligonucleotides	NULL
.	NULL

NF-KB	NULL
and	NULL
AP-1	NULL
binding	NULL
activities	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
plus	NULL
C3a	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
were	NULL
completely	NULL
abrogated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
,	NULL
but	NULL
remained	NULL
intact	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
Oct-1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
enhancing	NULL
effects	NULL
of	NULL
C3a	NULL
are	NULL
associated	NULL
with	NULL
an	NULL
increased	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
.	NULL

A	NULL
B	NULL
~~	NULL
#	NULL
nr-	NULL
«	NULL
s	NULL
-|	NULL
@	NULL
@	NULL
®	NULL
-~	NULL
av1-	NULL
>	NULL
|	NULL
(	NULL
@	NULL
wo	NULL
LPS	NULL
+	NULL
+	NULL
-	NULL
LPS	NULL
$	NULL
o	NULL
$	NULL
o	NULL
#	NULL
C3a	NULL
$	NULL
00	NULL
-	NULL
-	NULL
C330	NULL
@	NULL
-	NULL
o=	NULL
FIGURE	NULL
7	NULL
.	NULL

Effects	NULL
of	NULL
C3a	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
human	NULL
PBMCs	NULL
.	NULL

Shown	NULL
are	NULL
autoradiographs	NULL
of	NULL
EMSA	NULL
results	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
C3a	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
were	NULL
analyzed	NULL
.	NULL

P-labeled	NULL
22	NULL
mer	NULL
,	NULL
containing	NULL
the	NULL
consensus	NULL
sequences	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
GGGACTTTCC	NULL
;	NULL
A	NULL
)	NULL
or	NULL
AP-1	NULL
(	NULL
TGACTCA	NULL
;	NULL
B	NULL
)	NULL
,	NULL
was	NULL
used	NULL
for	NULL
EMSA	NULL
.	NULL

These	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

457	NULL
-	NULL
»	NULL
a	NULL
=t	NULL
LPS	NULL
+	NULL
-o	NULL
C3a	NULL
-o	NULL
0	NULL
#	NULL
0	NULL
FIGURE	NULL
8	NULL
.	NULL

Effects	NULL
of	NULL
C3a	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
human	NULL
PBMCs	NULL
.	NULL

Shown	NULL
are	NULL
autoradiographs	NULL
of	NULL
EMSA	NULL
results	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
C3a	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
were	NULL
analyzed	NULL
.	NULL

*°P-labeled	NULL
22-mer	NULL
,	NULL
containing	NULL
the	NULL
consensus	NULL
sequences	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
GGGACTTTCC	NULL
;	NULL
A	NULL
)	NULL
or	NULL
AP-1	NULL
(	NULL
TGACTCA	NULL
;	NULL
B	NULL
)	NULL
,	NULL
was	NULL
used	NULL
for	NULL
EMSA	NULL
.	NULL

These	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

Discussion	NULL
Involvement	NULL
of	NULL
anaphylatoxins	NULL
in	NULL
the	NULL
processes	NULL
of	NULL
inflammation	NULL
and	NULL
immunoregulation	NULL
is	NULL
supported	NULL
by	NULL
well-established	NULL
phenomena	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

The	NULL
purpose	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
investigate	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
biological	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C384	NULL
,	NULL
,4	NULL
,	NULL
,	NULL
On	NULL
human	NULL
PBMCs	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
C3a	NULL
on	NULL
cytokine	NULL
synthesis	NULL
are	NULL
poorly	NULL
defined	NULL
.	NULL

A	NULL
previous	NULL
report	NULL
demonstrated	NULL
that	NULL
C3a	NULL
stimulated	NULL
human	NULL
PBMCs	NULL
to	NULL
produce	NULL
IL-1	NULL
(	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
another	NULL
study	NULL
failed	NULL
to	NULL
show	NULL
IL-1	NULL
synthesis	NULL
in	NULL
PBMCs	NULL
in	NULL
response	NULL
to	NULL
C3a	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Regarding	NULL
C3a	NULL
as	NULL
an	NULL
inducer	NULL
of	NULL
cytokine	NULL
synthesis	NULL
,	NULL
this	NULL
latter	NULL
finding	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
our	NULL
results	NULL
as	NULL
well	NULL
as	NULL
other	NULL
published	NULL
data	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Neither	NULL
C3a	NULL
nor	NULL
C3aq	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
induced	NULL
IL-6	NULL
specific	NULL
mRNA	NULL
or	NULL
release	NULL
of	NULL
IL-6	NULL
in	NULL
human	NULL
PBMCs	NULL
.	NULL

Although	NULL
rapid	NULL
expression	NULL
of	NULL
cytokine	NULL
mRNA	NULL
in	NULL
monocytes	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
adherence	NULL
without	NULL
subsequent	NULL
translation	NULL
,	NULL
C3a	NULL
or	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
or	NULL
modify	NULL
IL-6	NULL
mRNA	NULL
synthesis	NULL
in	NULL
our	NULL
in	NULL
vitro	NULL
model	NULL
.	NULL

However	NULL
,	NULL
here	NULL
we	NULL
demonstrate	NULL
that	NULL
C3a	NULL
as	NULL
well	NULL
as	NULL
C32	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
increase	NULL
IL-6-specific	NULL
mRNA	NULL
and	NULL
protein	NULL
synthesis	NULL
by	NULL
human	NULL
PBMCs	NULL
after	NULL
stimulation	NULL
with	NULL
LPS	NULL
or	NULL
IL-1	NULL
.	NULL

The	NULL
C3a	NULL
analogue	NULL
peptide	NULL
71/53	NULL
also	NULL
enhanced	NULL
IL-6	NULL
release	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
observed	NULL
effects	NULL
of	NULL
C3a	NULL
are	NULL
specific	NULL
.	NULL

Recently	NULL
,	NULL
Takabayshi	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
C3a	NULL
and	NULL
C3aq	NULL
,	NULL
,	NULL
a	NULL
,	NULL
,	NULL
modulate	NULL
LPS-induced	NULL
mRNA	NULL
and	NULL
protein	NULL
synthesis	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
in	NULL
human	NULL
PBMCs	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
their	NULL
study	NULL
they	NULL
showed	NULL
that	NULL
synthesis	NULL
of	NULL
these	NULL
cytokines	NULL
was	NULL
up-regulated	NULL
in	NULL
adherent	NULL
PBMCs	NULL
,	NULL
whereas	NULL
they	NULL
were	NULL
down-regulated	NULL
in	NULL
nonadherent	NULL
PBMCs	NULL
.	NULL

Very	NULL
recently	NULL
,	NULL
these	NULL
studies	NULL
were	NULL
extended	NULL
to	NULL
demonstrate	NULL
the	NULL
same	NULL
effects	NULL
on	NULL
IL-6	NULL
production	NULL
(	NULL
39	NULL
)	NULL
.	NULL

In	NULL
our	NULL
study	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
a	NULL
difference	NULL
between	NULL
adherent	NULL
and	NULL
nonadherent	NULL
PBMCs	NULL
,	NULL
independent	NULL
of	NULL
the	NULL
concentration	NULL
of	NULL
LPS	NULL
employed	NULL
(	NULL
data	NULL
Competitor	NULL
Competitor	NULL
NF-B	NULL
Oct-1	NULL
AP-1	NULL
Oct-1	NULL
0	NULL
100x	NULL
100	NULL
%	NULL
B	NULL
0	NULL
100x	NULL
100	NULL
%	NULL
-	NULL
»	NULL
ﬂ	NULL
*	NULL
.	NULL

AP-1	NULL
-	NULL
»	NULL
|	NULL
P	NULL
Ca	NULL
FIGURE	NULL
9	NULL
.	NULL

Specificity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
binding	NULL
activity	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
C3a	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
were	NULL
used	NULL
for	NULL
analysis	NULL
of	NULL
the	NULL
NF-KB	NULL
(	NULL
4	NULL
)	NULL
or	NULL
AP-1	NULL
(	NULL
B	NULL
)	NULL
binding	NULL
activity	NULL
by	NULL
EMSA	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Zeft	NULL
lanes	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
competitive	NULL
unlabeled	NULL
oligonucleotides	NULL
(	NULL
100-fold	NULL
excess	NULL
)	NULL
.	NULL

Middle	NULL
lanes	NULL
,	NULL
Competition	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
(	NULL
A	NULL
)	NULL
or	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Right	NULL
lanes	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
Competition	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
Oct-1	NULL
binding	NULL
sequence	NULL
.	NULL

These	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
using	NULL
different	NULL
donors	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
458	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
currently	NULL
unclear	NULL
what	NULL
differences	NULL
in	NULL
our	NULL
experimental	NULL
systems	NULL
are	NULL
likely	NULL
to	NULL
account	NULL
to	NULL
the	NULL
discrepancies	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
study	NULL
we	NULL
demonstrated	NULL
C3a-induced	NULL
down-regula-tion	NULL
of	NULL
IL-6	NULL
and	NULL
TNF-a	NULL
release	NULL
in	NULL
human	NULL
tonsil-derived	NULL
B	NULL
lymphocytes	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggests	NULL
that	NULL
C3a	NULL
can	NULL
modulate	NULL
cytokine	NULL
synthesis	NULL
in	NULL
a	NULL
cell-specific	NULL
manner	NULL
.	NULL

Similar	NULL
effects	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
other	NULL
mediators	NULL
,	NULL
such	NULL
as	NULL
IL-4	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
IL-6	NULL
production	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
(	NULL
41	NULL
)	NULL
.	NULL

C3a	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
PGE	NULL
,	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
leading	NULL
to	NULL
increased	NULL
cAMP	NULL
levels	NULL
by	NULL
stimulation	NULL
of	NULL
adenylate	NULL
cy-clase	NULL
activity	NULL
.	NULL

These	NULL
signals	NULL
are	NULL
known	NULL
to	NULL
regulate	NULL
cytokine	NULL
production	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
indomethacin	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
cyclo-oxgenase	NULL
,	NULL
totally	NULL
suppressed	NULL
PGE	NULL
,	NULL
production	NULL
,	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
C3a-	NULL
and	NULL
C3a	NULL
,	NULL
__\	NULL
,	NULL
,	NULL
-mediated	NULL
increases	NULL
in	NULL
IL-6	NULL
expression	NULL
or	NULL
release	NULL
in	NULL
human	NULL
PBMCs	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
On	NULL
IL-6	NULL
production	NULL
in	NULL
LPS-	NULL
or	NULL
IL-1	NULL
B-stimulated	NULL
PBMCs	NULL
are	NULL
independent	NULL
of	NULL
endogenous	NULL
PGE	NULL
,	NULL
synthesis	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
those	NULL
published	NULL
by	NULL
Takabayashi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
15	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
receptor	NULL
for	NULL
human	NULL
C3a	NULL
was	NULL
cloned	NULL
and	NULL
was	NULL
found	NULL
to	NULL
belong	NULL
to	NULL
the	NULL
family	NULL
of	NULL
seven-transmembrane	NULL
receptors	NULL
(	NULL
32	NULL
,	NULL
33	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
several	NULL
biological	NULL
responses	NULL
of	NULL
C3a	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
PTX	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
C3a	NULL
receptor	NULL
acts	NULL
as	NULL
a	NULL
G	NULL
;	NULL
-coupled	NULL
receptor	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
show	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
both	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
on	NULL
IL-6	NULL
synthesis	NULL
were	NULL
totally	NULL
blocked	NULL
by	NULL
PTX	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
molecules	NULL
act	NULL
through	NULL
a	NULL
G	NULL
protein-dependent	NULL
pathway	NULL
,	NULL
possibly	NULL
involving	NULL
the	NULL
C3a	NULL
receptor	NULL
.	NULL

However	NULL
,	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
C	NULL
;	NULL
,4	NULL
,	NULL
,	NULL
.a	NULL
,	NULL
g	NULL
as	NULL
well	NULL
as	NULL
the	NULL
concentrations	NULL
of	NULL
C3a	NULL
and	NULL
required	NULL
to	NULL
elicit	NULL
enhancement	NULL
of	NULL
IL-6	NULL
production	NULL
are	NULL
inconsistent	NULL
with	NULL
the	NULL
currently	NULL
known	NULL
properties	NULL
of	NULL
the	NULL
receptor	NULL
on	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
33	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Definitive	NULL
assignment	NULL
of	NULL
a	NULL
receptor-mediated	NULL
mechanism	NULL
currently	NULL
awaits	NULL
the	NULL
generation	NULL
of	NULL
specific	NULL
receptor	NULL
antagonists	NULL
or	NULL
blocking	NULL
Abs	NULL
to	NULL
the	NULL
C3a	NULL
receptor	NULL
.	NULL

A	NULL
number	NULL
of	NULL
previous	NULL
studies	NULL
have	NULL
revealed	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
are	NULL
important	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
and	NULL
regulation	NULL
of	NULL
IL-6	NULL
transcription	NULL
.	NULL

The	NULL
major	NULL
form	NULL
of	NULL
NF-KB	NULL
is	NULL
a	NULL
heterodimer	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
that	NULL
exist	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
due	NULL
to	NULL
association	NULL
with	NULL
the	NULL
specific	NULL
inhibitor	NULL
protein	NULL
IB	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IB	NULL
by	NULL
candidate	NULL
kinases	NULL
leads	NULL
to	NULL
the	NULL
release	NULL
and	NULL
subsequent	NULL
nuclear	NULL
translo-cation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
then	NULL
binds	NULL
to	NULL
a	NULL
decameric	NULL
DNA	NULL
sequence	NULL
originally	NULL
identified	NULL
in	NULL
the	NULL
x	NULL
light	NULL
chain	NULL
enhancer	NULL
of	NULL
Ig	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
AP-1	NULL
is	NULL
a	NULL
heterodimer	NULL
formed	NULL
by	NULL
a	NULL
product	NULL
of	NULL
the	NULL
fos	NULL
and	NULL
jun	NULL
families	NULL
(	NULL
46	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
show	NULL
that	NULL
the	NULL
enhancing	NULL
activities	NULL
of	NULL
C3a	NULL
on	NULL
IL-6	NULL
expression	NULL
in	NULL
LPS-stimulated	NULL
PBMCs	NULL
are	NULL
associated	NULL
with	NULL
increased	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
to	NULL
their	NULL
consensus	NULL
sequences	NULL
.	NULL

Unexpectedly	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
C3a	NULL
alone	NULL
also	NULL
showed	NULL
elevated	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
compared	NULL
with	NULL
those	NULL
from	NULL
untreated	NULL
cells	NULL
.	NULL

Despite	NULL
this	NULL
observation	NULL
,	NULL
C3a	NULL
was	NULL
not	NULL
able	NULL
to	NULL
induce	NULL
IL-6	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
the	NULL
studies	NULL
by	NULL
Takabayashi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
C3a	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
IL-1	NULL
B	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
or	NULL
IL-6	NULL
(	NULL
15	NULL
,	NULL
39	NULL
)	NULL
.	NULL

A	NULL
possible	NULL
explanation	NULL
could	NULL
be	NULL
that	NULL
other	NULL
transcription	NULL
factors	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
NF-IL-6	NULL
and	NULL
SP-1	NULL
)	NULL
are	NULL
not	NULL
inducible	NULL
by	NULL
C3a	NULL
(	NULL
47	NULL
)	NULL
.	NULL

A	NULL
study	NULL
by	NULL
Matsusaka	NULL
et	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
showed	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NFE-IL-6	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50/p65	NULL
)	NULL
,	NULL
or	NULL
any	NULL
other	NULL
combination	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
IL-6	NULL
expression	NULL
was	NULL
not	NULL
inducible	NULL
in	NULL
a	NULL
cotransfection	NULL
system	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
a	NULL
cooperative	NULL
effect	NULL
exists	NULL
among	NULL
these	NULL
transcription	NULL
factors	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
LeClair	NULL
et	NULL
al	NULL
.	NULL

(	NULL
49	NULL
)	NULL
found	NULL
that	NULL
p50	NULL
and	NULL
NF-IL-6	NULL
directly	NULL
associate	NULL
with	NULL
each	NULL
other	NULL
via	NULL
the	NULL
b-Zip	NULL
domain	NULL
and	NULL
the	NULL
Rel	NULL
ho-mology	NULL
domain	NULL
.	NULL

These	NULL
data	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
C3a	NULL
alone	NULL
might	NULL
be	NULL
competent	NULL
to	NULL
induce	NULL
the	NULL
transcription	NULL
of	NULL
yet	NULL
uninvesti-	NULL
REGULATION	NULL
OF	NULL
IL-6	NULL
SYNTHESIS	NULL
BY	NULL
C3a	NULL
gated	NULL
genes	NULL
by	NULL
inducing	NULL
binding	NULL
activity	NULL
of	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
report	NULL
showing	NULL
that	NULL
the	NULL
anaphylatoxin	NULL
C3a	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
namely	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
,	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
regulators	NULL
of	NULL
many	NULL
immune	NULL
response	NULL
and	NULL
acute	NULL
phase	NULL
response	NULL
genes	NULL
,	NULL
including	NULL
IL-8	NULL
,	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
granulocyte	NULL
CSF	NULL
,	NULL
Ig	NULL
x	NULL
light	NULL
chain	NULL
,	NULL
and	NULL
serum	NULL
amyloid	NULL
A-1	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
C3a	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
immunological	NULL
functions	NULL
in	NULL
vivo	NULL
.	NULL

Surprisingly	NULL
,	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
shared	NULL
the	NULL
ability	NULL
to	NULL
enhance	NULL
IL-6	NULL
production	NULL
with	NULL
C3a	NULL
.	NULL

which	NULL
lacks	NULL
the	NULL
C-terminal	NULL
arginine	NULL
,	NULL
has	NULL
generally	NULL
been	NULL
regarded	NULL
to	NULL
be	NULL
biologically	NULL
inactive	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

is	NULL
not	NULL
chemotactic	NULL
for	NULL
eosinophils	NULL
(	NULL
13	NULL
)	NULL
,	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
specific	NULL
receptors	NULL
on	NULL
guinea	NULL
pig	NULL
platelets	NULL
(	NULL
50	NULL
)	NULL
or	NULL
on	NULL
a	NULL
human	NULL
mast	NULL
cell	NULL
line	NULL
(	NULL
52	NULL
)	NULL
,	NULL
and	NULL
does	NULL
not	NULL
induce	NULL
calcium	NULL
mobilization	NULL
in	NULL
either	NULL
human	NULL
mast	NULL
cells	NULL
(	NULL
52	NULL
)	NULL
or	NULL
human	NULL
monocytes	NULL
(	NULL
53	NULL
)	NULL
,	NULL
all	NULL
properties	NULL
that	NULL
have	NULL
been	NULL
demonstrated	NULL
by	NULL
the	NULL
intact	NULL
molecule	NULL
.	NULL

Because	NULL
the	NULL
C-terminal	NULL
arginine	NULL
is	NULL
rapidly	NULL
cleaved	NULL
by	NULL
serum	NULL
carboxypeptidase	NULL
N	NULL
to	NULL
convert	NULL
C3a	NULL
to	NULL
C3aq	NULL
.	NULL

,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
this	NULL
enzymatic	NULL
process	NULL
has	NULL
been	NULL
considered	NULL
a	NULL
major	NULL
mechanism	NULL
for	NULL
controlling	NULL
C3a	NULL
function	NULL
in	NULL
vivo	NULL
(	NULL
51	NULL
)	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
reported	NULL
biological	NULL
activities	NULL
for	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
including	NULL
inhibition	NULL
of	NULL
cytotoxicity	NULL
by	NULL
human	NULL
NK	NULL
cells	NULL
(	NULL
54	NULL
)	NULL
,	NULL
induction	NULL
of	NULL
histamine	NULL
release	NULL
from	NULL
rat	NULL
peri-toneal	NULL
mast	NULL
cells	NULL
(	NULL
55	NULL
)	NULL
,	NULL
regulation	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
in	NULL
human	NULL
PBMC	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
regulation	NULL
of	NULL
B	NULL
cell	NULL
function	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Both	NULL
C3a	NULL
and	NULL
C324	NULL
,	NULL
,	NULL
arg	NULL
are	NULL
highly	NULL
cationic	NULL
molecules	NULL
that	NULL
can	NULL
bind	NULL
to	NULL
anionic	NULL
components	NULL
on	NULL
the	NULL
cell	NULL
membrane	NULL
,	NULL
leading	NULL
to	NULL
nonspecific	NULL
cell	NULL
activation	NULL
(	NULL
55	NULL
)	NULL
.	NULL

This	NULL
nonspecific	NULL
effect	NULL
,	NULL
which	NULL
depends	NULL
on	NULL
the	NULL
net	NULL
charge	NULL
of	NULL
the	NULL
molecules	NULL
,	NULL
could	NULL
explain	NULL
why	NULL
C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
and	NULL
C3a	NULL
share	NULL
some	NULL
biological	NULL
activities	NULL
.	NULL

There	NULL
is	NULL
also	NULL
evidence	NULL
that	NULL
C3a	NULL
(	NULL
and	NULL
possibly	NULL
binds	NULL
to	NULL
the	NULL
-chain	NULL
of	NULL
the	NULL
Fee	NULL
receptor	NULL
on	NULL
mast	NULL
cells	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Similar	NULL
Fc	NULL
interactions	NULL
on	NULL
monocytes	NULL
could	NULL
influence	NULL
the	NULL
signaling	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

However	NULL
,	NULL
the	NULL
question	NULL
remains	NULL
as	NULL
to	NULL
why	NULL
C3a	NULL
,	NULL
_.	NULL
,	NULL
,	NULL
,	NULL
activity	NULL
is	NULL
observed	NULL
in	NULL
some	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
cell	NULL
types	NULL
responding	NULL
to	NULL
C3a	NULL
.	NULL

A	NULL
possible	NULL
explanation	NULL
would	NULL
be	NULL
differences	NULL
in	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
these	NULL
cell	NULL
types	NULL
.	NULL

An	NULL
even	NULL
more	NULL
speculative	NULL
possibility	NULL
would	NULL
be	NULL
that	NULL
there	NULL
is	NULL
a	NULL
second	NULL
receptor	NULL
for	NULL
C3a	NULL
and/or	NULL
C3a,4	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
.	NULL

Two	NULL
groups	NULL
who	NULL
have	NULL
cloned	NULL
the	NULL
C3aR	NULL
found	NULL
a	NULL
second	NULL
band	NULL
in	NULL
their	NULL
Northern	NULL
blots	NULL
supporting	NULL
this	NULL
possibility	NULL
(	NULL
33	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
that	NULL
a	NULL
synthetic	NULL
peptide	NULL
analogue	NULL
of	NULL
C3a	NULL
mimics	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
and	NULL
that	NULL
both	NULL
the	NULL
effects	NULL
of	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
are	NULL
inhibited	NULL
by	NULL
PTX	NULL
support	NULL
a	NULL
re-ceptor-mediated	NULL
signaling	NULL
pathway	NULL
.	NULL

Nevertheless	NULL
,	NULL
more	NULL
studies	NULL
are	NULL
necessary	NULL
to	NULL
identify	NULL
receptor	NULL
vs	NULL
nonreceptor	NULL
mechanisms	NULL
of	NULL
cellular	NULL
activation	NULL
by	NULL
C3a	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
mechanism	NULL
,	NULL
the	NULL
enhancing	NULL
effect	NULL
of	NULL
C3a/C3a	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
on	NULL
IL-6	NULL
production	NULL
in	NULL
LPS-	NULL
and	NULL
IL-1	NULL
B-stimulated	NULL
PBMCs	NULL
is	NULL
readily	NULL
demonstrated	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
by	NULL
influencing	NULL
IL-6	NULL
production	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
and	NULL
PBMCs	NULL
,	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
..	NULL
,	NULL
,	NULL
,	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
both	NULL
immune	NULL
responses	NULL
and	NULL
inflammation	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
this	NULL
is	NULL
the	NULL
first	NULL
report	NULL
showing	NULL
a	NULL
biological	NULL
function	NULL
of	NULL
C3	NULL
@	NULL
Of	NULL
C3	NULL
@	NULL
qesa	NULL
;	NULL
$	NULL
that	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
binding	NULL
activities	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Philippe	NULL
Pfeifer	NULL
for	NULL
purification	NULL
of	NULL
the	NULL
C3a	NULL
,	NULL
and	NULL
Alicia	NULL
Palestini	NULL
for	NULL
her	NULL
help	NULL
in	NULL
preparing	NULL
this	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Weinberg	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
M.	NULL
A.	NULL
Matthay	NULL
,	NULL
O.	NULL
Webster	NULL
,	NULL
K.	NULL
V.	NULL
Roskos	NULL
,	NULL
I.	NULL
M.	NULL
Goldstein	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Murray	NULL
.	NULL

1984	NULL
.	NULL

Biologically	NULL
active	NULL
products	NULL
of	NULL
complement	NULL
and	NULL
acute	NULL
lung	NULL
injury	NULL
in	NULL
patients	NULL
with	NULL
sepsis	NULL
syndrome	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

130:791	NULL
.	NULL

2	NULL
.	NULL

Bengston	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
Heideman	NULL
.	NULL

1988	NULL
.	NULL

Anaphylatoxin	NULL
formation	NULL
in	NULL
sepsis	NULL
.	NULL

Arch	NULL
.	NULL

Surg	NULL
.	NULL

123:645	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29.	NULL
.	NULL

Heideman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
T.	NULL
E.	NULL
Hugli	NULL
.	NULL

1984	NULL
.	NULL

Anaphylatoxin	NULL
generation	NULL
in	NULL
multisystem	NULL
organ	NULL
failure	NULL
.	NULL

J.	NULL
Trauma	NULL
24:1038.	NULL
.	NULL

Zilow	NULL
,	NULL
G.	NULL
,	NULL
T.	NULL
Joka	NULL
,	NULL
U.	NULL
Obertacke	NULL
,	NULL
U.	NULL
Rother	NULL
,	NULL
and	NULL
M.	NULL
Kirschfink	NULL
.	NULL

1992	NULL
.	NULL

Generation	NULL
of	NULL
anaphylatoxin	NULL
C3a	NULL
in	NULL
plasma	NULL
and	NULL
bronchoalveolar	NULL
lavage	NULL
fluid	NULL
in	NULL
trauma	NULL
patients	NULL
at	NULL
risk	NULL
for	NULL
adult	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

20:468.	NULL
.	NULL

Belmont	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
P.	NULL
Hopkins	NULL
,	NULL
H.	NULL
S.	NULL
Edelson	NULL
,	NULL
H.	NULL
B.	NULL
Kaplan	NULL
,	NULL
R.	NULL
Ludewig	NULL
,	NULL
G.	NULL
Weissmann	NULL
,	NULL
and	NULL
S.	NULL
Abramson	NULL
.	NULL

1986	NULL
.	NULL

Complement	NULL
activation	NULL
during	NULL
systemic	NULL
lupus	NULL
erythematosus	NULL
:	NULL
C3a	NULL
and	NULL
CSa	NULL
anaphylatoxins	NULL
circulate	NULL
during	NULL
exacerbations	NULL
of	NULL
discase	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

29:1085.	NULL
.	NULL

Hugli	NULL
,	NULL
T.	NULL
E.	NULL
1981	NULL
.	NULL

The	NULL
structural	NULL
basis	NULL
for	NULL
anaphylatoxin	NULL
and	NULL
chemotactic	NULL
func-	NULL
tions	NULL
of	NULL
C3a	NULL
,	NULL
C42	NULL
,	NULL
and	NULL
CSa	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

1:321.	NULL
.	NULL

Hugli	NULL
,	NULL
T.	NULL
E.	NULL
1989	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
C3a	NULL
anaphylatoxin	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Mi	NULL
crobiol	NULL
.	NULL

Immunol	NULL
.	NULL

153:181.	NULL
.	NULL

Kohl	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Bitter-Suermann	NULL
.	NULL

1993	NULL
.	NULL

Anaphylatoxins	NULL
.	NULL

In	NULL
Complement	NULL
in	NULL
Health	NULL
and	NULL
Disease	NULL
.	NULL

K.	NULL
Whaley	NULL
,	NULL
M.	NULL
Loos	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Weiler	NULL
,	NULL
eds	NULL
.	NULL

Kluwer	NULL
Academic	NULL
Publishers	NULL
,	NULL
Lancaster	NULL
,	NULL
pp	NULL
.	NULL

299-324.	NULL
.	NULL

Goldstein	NULL
,	NULL
I.	NULL
M.	NULL
1992	NULL
.	NULL

Complement	NULL
:	NULL
biologically	NULL
active	NULL
products	NULL
.	NULL

In	NULL
Inflamma-	NULL
tion	NULL
:	NULL
Basic	NULL
Principles	NULL
and	NULL
Clinical	NULL
Correlates	NULL
.	NULL

J.	NULL
I.	NULL
Gallin	NULL
,	NULL
I.	NULL
M.	NULL
Goldstein	NULL
,	NULL
and	NULL
R.	NULL
Snyderman	NULL
,	NULL
eds	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
Ltd.	NULL
New	NULL
York	NULL
.	NULL

Goodman	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
D.	NULL
E.	NULL
Chenoweth	NULL
,	NULL
and	NULL
W.	NULL
O.	NULL
Weigle	NULL
.	NULL

1982	NULL
.	NULL

Induction	NULL
of	NULL
interleukin-1	NULL
secretion	NULL
and	NULL
enhancement	NULL
of	NULL
humoral	NULL
immunity	NULL
by	NULL
binding	NULL
of	NULL
CSa	NULL
to	NULL
macrophage	NULL
surface	NULL
CSa	NULL
receptors	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

156:912	NULL
.	NULL

Scholz	NULL
,	NULL
W.	NULL
,	NULL
M.	NULL
R.	NULL
McClurg	NULL
,	NULL
G.	NULL
J.	NULL
Cardenas	NULL
,	NULL
M.	NULL
Smith	NULL
,	NULL
D.	NULL
J.	NULL
Noonan	NULL
,	NULL
T.	NULL
E.	NULL
Hugli	NULL
,	NULL
and	NULL
E.	NULL
L.	NULL
Morgan	NULL
.	NULL

1990	NULL
.	NULL

CSa-mediated	NULL
release	NULL
of	NULL
interleukin-6	NULL
by	NULL
human	NULL
monocytes	NULL
.	NULL

Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

57:297	NULL
.	NULL

Schindler	NULL
,	NULL
R.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Gelfand	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1990	NULL
.	NULL

Recombinant	NULL
CSa	NULL
stimulates	NULL
transcription	NULL
rather	NULL
than	NULL
translation	NULL
of	NULL
IL-1	NULL
and	NULL
TNF	NULL
:	NULL
translational	NULL
signal	NULL
provided	NULL
by	NULL
LPS	NULL
or	NULL
IL-1	NULL
itself	NULL
.	NULL

Blood	NULL
76:1631	NULL
.	NULL

Daffern	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
P.	NULL
H.	NULL
Pfeifer	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ember	NULL
,	NULL
and	NULL
T.	NULL
E.	NULL
Hugli	NULL
.	NULL

1995	NULL
.	NULL

C3a	NULL
is	NULL
a	NULL
che-motaxin	NULL
for	NULL
human	NULL
eosinophils	NULL
but	NULL
not	NULL
for	NULL
neutrophils	NULL
.	NULL

I.	NULL
C3a	NULL
stimulation	NULL
of	NULL
neutrophils	NULL
is	NULL
secondary	NULL
to	NULL
eosinophil	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:2119	NULL
.	NULL

Morgan	NULL
,	NULL
E.	NULL
L.	NULL
1987	NULL
.	NULL

The	NULL
role	NULL
of	NULL
prostaglandins	NULL
in	NULL
C3a-mediated	NULL
suppression	NULL
of	NULL
human	NULL
in	NULL
vitro	NULL
polyclonal	NULL
antibody	NULL
responses	NULL
.	NULL

Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

44:1	NULL
.	NULL

Takabayashi	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
Vannier	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
N.	NULL
H.	NULL
Margolis	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
J.	NULL
F.	NULL
Burke	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Gelfand	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
new	NULL
biologic	NULL
role	NULL
for	NULL
C3a	NULL
and	NULL
C3a	NULL
desArg	NULL
:	NULL
regulation	NULL
of	NULL
TNF-alpha	NULL
and	NULL
IL-1beta	NULL
synthesis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:3455	NULL
.	NULL

Nilsson	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Johnell	NULL
,	NULL
C.	NULL
H.	NULL
Hammer	NULL
,	NULL
H.	NULL
L.	NULL
Tiffany	NULL
,	NULL
K.	NULL
Nilsson	NULL
,	NULL
D.	NULL
D.	NULL
Metcalfe	NULL
,	NULL
A.	NULL
Siegbahn	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Murphy	NULL
.	NULL

1996	NULL
.	NULL

C3a	NULL
and	NULL
C5a	NULL
are	NULL
chemotaxins	NULL
for	NULL
human	NULL
mast	NULL
cells	NULL
and	NULL
act	NULL
through	NULL
distinct	NULL
receptors	NULL
via	NULL
a	NULL
pertussis	NULL
toxin-sensitive	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:1693	NULL
.	NULL

Fischer	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
E.	NULL
Hugli	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
B	NULL
cell	NULL
function	NULL
by	NULL
C3a	NULL
and	NULL
C3adesArg	NULL
:	NULL
suppression	NULL
of	NULL
TNF-	NULL
@	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
the	NULL
polyclonal	NULL
immune	NULL
response	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:4279	NULL
.	NULL

Van	NULL
Damme	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Cayphas	NULL
,	NULL
G.	NULL
Opdenakker	NULL
,	NULL
A.	NULL
Billiau	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Van	NULL
Snick	NULL
.	NULL

1987	NULL
.	NULL

Interleukin-1	NULL
and	NULL
poly	NULL
(	NULL
rD	NULL
)	NULL
:	NULL
poly	NULL
(	NULL
rC	NULL
)	NULL
induce	NULL
production	NULL
of	NULL
a	NULL
hybridoma	NULL
growth	NULL
factor	NULL
by	NULL
human	NULL
fibroblasts	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

17:1	NULL
.	NULL

Sironi	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
Breviario	NULL
,	NULL
P.	NULL
Proserpio	NULL
,	NULL
A.	NULL
Biondi	NULL
,	NULL
A.	NULL
Vecchi	NULL
,	NULL
J	NULL
.	NULL

Van	NULL
Damme	NULL
,	NULL
E.	NULL
Dejana	NULL
,	NULL
and	NULL
A.	NULL
Mantovani	NULL
.	NULL

1989	NULL
.	NULL

IL-1	NULL
stimulates	NULL
IL-6	NULL
production	NULL
in	NULL
endothe-lial	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142	NULL
;	NULL
:549	NULL
.	NULL

Jablons	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
J.	NULL
J.	NULL
Mule	NULL
,	NULL
J.	NULL
K.	NULL
Macintosh	NULL
,	NULL
P.	NULL
B.	NULL
Sehgal	NULL
,	NULL
L.	NULL
T.	NULL
May	NULL
,	NULL
C.	NULL
M.	NULL
Huang	NULL
,	NULL
S.	NULL
A.	NULL
Rosenberg	NULL
,	NULL
and	NULL
M.	NULL
T.	NULL
Lotze	NULL
.	NULL

1989	NULL
.	NULL

IL-6/IFN-B2	NULL
as	NULL
a	NULL
circulating	NULL
hormone	NULL
:	NULL
induction	NULL
by	NULL
cytokine	NULL
administration	NULL
in	NULL
humans	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:1542	NULL
.	NULL

Kohase	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Henrikson-DeStefano	NULL
,	NULL
L.	NULL
T.	NULL
May	NULL
,	NULL
J.	NULL
Vileck	NULL
,	NULL
and	NULL
P.	NULL
B.	NULL
Schgal	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
B2-interferon	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
:	NULL
a	NULL
homeostatic	NULL
mechanism	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cell	NULL
proliferation	NULL
.	NULL

Cell	NULL
45:659	NULL
.	NULL

Le	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
Vileek	NULL
.	NULL

1989	NULL
.	NULL

Interleukin-6	NULL
:	NULL
a	NULL
multifunctional	NULL
cytokine	NULL
regulating	NULL
immune	NULL
reaction	NULL
and	NULL
the	NULL
acute	NULL
phase	NULL
protein	NULL
response	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

61:588	NULL
.	NULL

Van	NULL
Snick	NULL
,	NULL
J	NULL
.	NULL

1990	NULL
.	NULL

Interleukin-6	NULL
:	NULL
An	NULL
overview	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

8:253	NULL
.	NULL

Scholz	NULL
,	NULL
W.	NULL
1996	NULL
.	NULL

Interleukin-6	NULL
in	NULL
diseases	NULL
:	NULL
cause	NULL
or	NULL
cure	NULL
?	NULL

Immunopharmacology	NULL
31:131	NULL
.	NULL

Paquet	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Picrard	NULL
.	NULL

1996	NULL
.	NULL

Interleukin-6	NULL
and	NULL
the	NULL
skin	NULL
.	NULL

Int	NULL
.	NULL

Arch	NULL
.	NULL

Allergy	NULL
Immunol	NULL
.	NULL

109:308	NULL
.	NULL

Ember	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
D.	NULL
Sanderson	NULL
,	NULL
T.	NULL
E.	NULL
Hugli	NULL
,	NULL
and	NULL
E.	NULL
L.	NULL
Morgan	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
Interleukin-8	NULL
synthesis	NULL
from	NULL
monocytes	NULL
by	NULL
human	NULL
CSa	NULL
anaphylatoxin	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

144:393	NULL
.	NULL

Hugli	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
C.	NULL
Gerard	NULL
,	NULL
M.	NULL
Kawahara	NULL
,	NULL
M.	NULL
E.	NULL
Scheetz	NULL
,	NULL
R.	NULL
Barton	NULL
,	NULL
S.	NULL
Briggs	NULL
,	NULL
G.	NULL
Koppel	NULL
,	NULL
and	NULL
S.	NULL
Russell	NULL
.	NULL

1981	NULL
.	NULL

Isolation	NULL
of	NULL
three	NULL
separate	NULL
anaphylatoxins	NULL
from	NULL
complement-activated	NULL
human	NULL
serum	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

41:59	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475	NULL
.	NULL

Kravchenko	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
Z.	NULL
Pan	NULL
,	NULL
J.	NULL
Han	NULL
,	NULL
J.-M.	NULL
Herbert	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Ye	NULL
.	NULL

1995	NULL
.	NULL

Platelet-activating	NULL
factor	NULL
induces	NULL
NF-KB	NULL
activation	NULL
through	NULL
a	NULL
G	NULL
protein-coupled	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:14928	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

459	NULL
Ember	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
N.	NULL
L.	NULL
Johansen	NULL
,	NULL
and	NULL
T.	NULL
E.	NULL
Hugli	NULL
.	NULL

1991	NULL
.	NULL

Designing	NULL
synthetic	NULL
super-agonist	NULL
of	NULL
C3a	NULL
anaphylatoxin	NULL
.	NULL

Biochemistry	NULL
30:3603	NULL
.	NULL

Knudsen	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
and	NULL
T.	NULL
B.	NULL
Strom	NULL
.	NULL

1986	NULL
.	NULL

Prostaglandins	NULL
posttran-scriptionally	NULL
inhibit	NULL
monocyte	NULL
expression	NULL
of	NULL
interleukin	NULL
1	NULL
activity	NULL
by	NULL
increasing	NULL
intracellular	NULL
cyclic	NULL
adenosine	NULL
monophosphate	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

137:3189	NULL
.	NULL

Ames	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
H.	NULL
M.	NULL
Sarau	NULL
,	NULL
P.	NULL
Nuthulaganti	NULL
,	NULL
J.	NULL
J.	NULL
Foley	NULL
,	NULL
C.	NULL
Ellis	NULL
,	NULL
Z.	NULL
Zeng	NULL
,	NULL
K.	NULL
Su	NULL
,	NULL
A.	NULL
J.	NULL
Jurewicz	NULL
,	NULL
R.	NULL
P.	NULL
Hertzberg	NULL
,	NULL
D.	NULL
J.	NULL
Bergsma	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
anaphylatoxin	NULL
C3a	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
20231	NULL
.	NULL

Crass	NULL
,	NULL
T.	NULL
,	NULL
U.	NULL
Raffetseder	NULL
,	NULL
U.	NULL
Martin	NULL
,	NULL
M.	NULL
Grove	NULL
,	NULL
A.	NULL
Klos	NULL
,	NULL
J.	NULL
Kohl	NULL
,	NULL
and	NULL
W.	NULL
Bautsch	NULL
.	NULL

1996	NULL
.	NULL

Expression	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
C3a	NULL
anaphylatoxin	NULL
receptor	NULL
(	NULL
C3aR	NULL
)	NULL
from	NULL
differentiated	NULL
U-937	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

26:1944	NULL
.	NULL

Shimizu	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
NF-B-like	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
interleukin-6	NULL
gene	NULL
by	NULL
inflammatory	NULL
lymphokines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:561	NULL
.	NULL

Libermann	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-6	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2327	NULL
.	NULL

Hacgeman	NULL
,	NULL
G.	NULL
,	NULL
J	NULL
.	NULL

Content	NULL
,	NULL
G.	NULL
Volkaert	NULL
,	NULL
R.	NULL
Derynck	NULL
,	NULL
J.	NULL
Tavernier	NULL
,	NULL
and	NULL
W.	NULL
Fiers	NULL
.	NULL

1986	NULL
.	NULL

Structural	NULL
analysis	NULL
of	NULL
the	NULL
sequence	NULL
encoding	NULL
for	NULL
an	NULL
inducible	NULL
26-kDa	NULL
protein	NULL
in	NULL
human	NULL
fibroblasts	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

159:625	NULL
.	NULL

Hacffner-Cavaillon	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
M.	NULL
Cavaillon	NULL
,	NULL
M.	NULL
Laude	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Kazatchkine	NULL
.	NULL

1987	NULL
.	NULL

C3a	NULL
(	NULL
C3ades-Arg	NULL
)	NULL
induces	NULL
production	NULL
and	NULL
release	NULL
of	NULL
interleukin	NULL
1	NULL
by	NULL
cultured	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

139:794	NULL
.	NULL

Arend	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
R.	NULL
J.	NULL
Massoni	NULL
,	NULL
M.	NULL
A.	NULL
Niemann	NULL
,	NULL
and	NULL
P.	NULL
C.	NULL
Giclas	NULL
.	NULL

1989	NULL
.	NULL

Absence	NULL
of	NULL
induction	NULL
of	NULL
IL-1	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
by	NULL
complement	NULL
fragments	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:173	NULL
.	NULL

Takabayashi	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
Vannier	NULL
,	NULL
J.	NULL
F.	NULL
Burke	NULL
,	NULL
R.	NULL
G.	NULL
Tompkins	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Gelfand	NULL
,	NULL
and	NULL
B.	NULL
D.	NULL
Clark	NULL
.	NULL

1998	NULL
.	NULL

Both	NULL
C3a	NULL
and	NULL
C3a	NULL
,	NULL
..	NULL
,	NULL
.	NULL

,	NULL
regulate	NULL
Interleukin-6	NULL
synthesis	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

177:1622	NULL
.	NULL

Fischer	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
M.	NULL
Ma	NULL
,	NULL
S.	NULL
Goerg	NULL
,	NULL
X.	NULL
Zhou	NULL
,	NULL
J.	NULL
Xia	NULL
,	NULL
O.	NULL
Finco	NULL
,	NULL
S.	NULL
Han	NULL
,	NULL
G.	NULL
Kelsoc	NULL
,	NULL
R.	NULL
G.	NULL
Howard	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
response	NULL
to	NULL
T-dependent	NULL
antigens	NULL
by	NULL
classical	NULL
pathway	NULL
complement	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:549	NULL
.	NULL

Donnelly	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
L.	NULL
J.	NULL
Crofford	NULL
,	NULL
S.	NULL
L.	NULL
Freeman	NULL
,	NULL
J.	NULL
Buras	NULL
,	NULL
E.	NULL
Remmers	NULL
,	NULL
R.	NULL
L.	NULL
Wilder	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Fenton	NULL
.	NULL

1993	NULL
.	NULL

Tissue-specific	NULL
regulation	NULL
of	NULL
IL-6	NULL
production	NULL
by	NULL
IL-4	NULL
:	NULL
differential	NULL
effects	NULL
of	NULL
IL-4	NULL
on	NULL
nuclear	NULL
factor-kB	NULL
activity	NULL
in	NULL
monocytes	NULL
and	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:5603	NULL
.	NULL

Roglic	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
R.	NULL
Prossnitz	NULL
,	NULL
S.	NULL
L.	NULL
Cavanagh	NULL
,	NULL
Z.	NULL
Pan	NULL
,	NULL
A.	NULL
Zou	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Ye	NULL
.	NULL

1996.	NULL
cDNA	NULL
cloning	NULL
of	NULL
a	NULL
novel	NULL
G	NULL
protein-coupled	NULL
receptor	NULL
with	NULL
a	NULL
large	NULL
extracellular	NULL
loop	NULL
structure	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1305:39	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Anru	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

NF-KB	NULL
:	NULL
ten	NULL
years	NULL
after	NULL
.	NULL

Cell	NULL
87:13	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
im-munglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46:705	NULL
.	NULL

Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Franza	NULL
.	NULL

1988	NULL
.	NULL

Fos	NULL
and	NULL
Jun	NULL
:	NULL
the	NULL
AP-1	NULL
connection	NULL
.	NULL

Cell	NULL
55:395	NULL
.	NULL

Kang	NULL
,	NULL
S.-H.	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
I.	NULL
Kitajima	NULL
,	NULL
X.	NULL
X.	NULL
,	NULL
O.	NULL
Heidenreich	NULL
,	NULL
S.	NULL
Gryaznov	NULL
,	NULL
and	NULL
M.	NULL
Nerenberg	NULL
.	NULL

1996	NULL
.	NULL

Binding	NULL
and	NULL
functional	NULL
effects	NULL
of	NULL
transcriptional	NULL
factor	NULL
Spl	NULL
on	NULL
the	NULL
murine	NULL
interleukin-6	NULL
promotor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:7330	NULL
.	NULL

Matsusaka	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
N.	NULL
Mukaida	NULL
,	NULL
K.	NULL
Matsushima	NULL
,	NULL
T.	NULL
Kishimoto	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
factors	NULL
NFB-IL6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
syn-ergistically	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
interleukin	NULL
6	NULL
and	NULL
interleukin	NULL
8	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10193	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
pSQ	NULL
subunit	NULL
of	NULL
NF-KB	NULL
associates	NULL
with	NULL
the	NULL
NF-IL6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
;	NULL
8145	NULL
.	NULL

Fukuoka	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
T.	NULL
E.	NULL
Hugli	NULL
.	NULL

1988	NULL
.	NULL

Demonstration	NULL
of	NULL
a	NULL
specific	NULL
C3a	NULL
receptor	NULL
on	NULL
guinea	NULL
pig	NULL
platelets	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:3496	NULL
.	NULL

Bokisch	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
and	NULL
H.	NULL
J.	NULL
Miiller-Eberhard	NULL
.	NULL

1970	NULL
.	NULL

Anaphylatoxin	NULL
inactivator	NULL
of	NULL
human	NULL
plasma	NULL
:	NULL
its	NULL
isolation	NULL
and	NULL
characterization	NULL
as	NULL
a	NULL
carboxypeptidase	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

49:2427	NULL
.	NULL

Zwimer	NULL
,	NULL
J.	NULL
,	NULL
O.	NULL
Gotze	NULL
,	NULL
A.	NULL
Sicber	NULL
,	NULL
A.	NULL
Kapp	NULL
,	NULL
G.	NULL
Begemann	NULL
,	NULL
T.	NULL
Zuberbier	NULL
,	NULL
and	NULL
T.	NULL
Werfel	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
human	NULL
mast	NULL
cell	NULL
line	NULL
HMC-1	NULL
binds	NULL
and	NULL
responds	NULL
to	NULL
C3a	NULL
but	NULL
not	NULL
C3a	NULL
(	NULL
desArg	NULL
)	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

47:19	NULL
.	NULL

Zwimer	NULL
,	NULL
J.	NULL
,	NULL
O.	NULL
Gotze	NULL
,	NULL
A.	NULL
Mosier	NULL
,	NULL
A.	NULL
Sieber	NULL
,	NULL
A.	NULL
Kapp	NULL
,	NULL
G.	NULL
Begemann	NULL
,	NULL
J.	NULL
Elsner	NULL
,	NULL
and	NULL
T.	NULL
Werfel	NULL
.	NULL

1997	NULL
.	NULL

Blood-	NULL
and	NULL
skin-derived	NULL
monocytes/macrophages	NULL
respond	NULL
to	NULL
C3a	NULL
but	NULL
not	NULL
to	NULL
C3a	NULL
(	NULL
desArg	NULL
)	NULL
with	NULL
a	NULL
transient	NULL
release	NULL
of	NULL
calcium	NULL
via	NULL
a	NULL
pertussis	NULL
toxin-sensitive	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:2317	NULL
.	NULL

Charriaut	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Senik	NULL
,	NULL
J.-P.	NULL
Kolb	NULL
,	NULL
M.	NULL
Barel	NULL
,	NULL
and	NULL
R.	NULL
Frade	NULL
.	NULL

1982	NULL
.	NULL

Inhibition	NULL
of	NULL
in	NULL
vitro	NULL
natural	NULL
killer	NULL
activity	NULL
by	NULL
the	NULL
third	NULL
component	NULL
of	NULL
complement	NULL
:	NULL
role	NULL
for	NULL
the	NULL
C3a	NULL
fragment	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:6003	NULL
.	NULL

Mousli	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
E.	NULL
Hugli	NULL
,	NULL
Y.	NULL
Landry	NULL
,	NULL
and	NULL
C.	NULL
Bronner	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
mechanism	NULL
of	NULL
action	NULL
for	NULL
anaphylatoxin	NULL
C3a	NULL
stimulation	NULL
of	NULL
mast	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:2456	NULL
.	NULL

Erdei	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
I.	NULL
Pecht	NULL
.	NULL

1996	NULL
.	NULL

Complement	NULL
peptides	NULL
and	NULL
mast	NULL
cell	NULL
triggering	NULL
.	NULL

Immunol	NULL
.	NULL

Lett	NULL
.	NULL

54:109	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

